Abliva AB

Sweden

Back to Profile

1-42 of 42 for Abliva AB Sort by
Query
Aggregations
IP Type
        Patent 24
        Trademark 18
Jurisdiction
        United States 19
        World 11
        Canada 7
        Europe 5
Date
New (last 4 weeks) 2
2025 February (MTD) 2
2025 (YTD) 2
2024 1
2023 1
See more
IPC Class
C07C 327/30 - Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups 7
A61K 31/4184 - 1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles 5
A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system 5
A61K 31/265 - Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid 4
A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca 4
See more
NICE Class
05 - Pharmaceutical, veterinary and sanitary products 14
42 - Scientific, technological and industrial services, research and design 14
09 - Scientific and electric apparatus and instruments 9
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services 9
10 - Medical apparatus and instruments 7
See more
Status
Pending 4
Registered / In Force 38

1.

QUINONES FOR USE IN THE TREATMENT OF RED BLOOD CELL ENZYMOPATHIES

      
Application Number EP2024073371
Publication Number 2025/040685
Status In Force
Filing Date 2024-08-20
Publication Date 2025-02-27
Owner ABLIVA AB (Sweden)
Inventor
  • Hansson, Magnus Joakim
  • Elmér, Mats Eskil
  • Moss, Steven James

Abstract

Class of quinones for use in the treatment restoring, normalizing and/or improving ATP in cells lacking mitochondria, such as red blood cells. Specific example is use in the treatment of red blood cell enzymopathies, especially in the treatment of defects in red blood cell metabolism such as defects in red blood cell glycolysis. The treatment increases ATP in non-mitochondrial cells. Thus, the present invention relates to a class of quinones for use in the treatment of diseases or conditions associated with or caused by defects in red blood cell glycolysis.

IPC Classes  ?

  • A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
  • A61K 31/343 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
  • A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
  • A61P 7/06 - Antianaemics
  • A61K 31/4184 - 1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles

2.

QUINONES FOR USE IN THE TREATMENT OF RED BLOOD CELL ENZYMOPATHIES

      
Application Number EP2024073372
Publication Number 2025/040686
Status In Force
Filing Date 2024-08-20
Publication Date 2025-02-27
Owner ABLIVA AB (Sweden)
Inventor
  • Hansson, Magnus Joakim
  • Elmér, Mats Eskil
  • Moss, Steven James

Abstract

Classes of quinones for use in the treatment of red blood cell enzymopathologies. The treatment increases ATP in non-mitochondrial cells. Thus, the present invention relates to classes of quinones for use in the treatment of diseases or conditions associated with or caused by defects in red blood cell glycolysis.

IPC Classes  ?

  • A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
  • A61K 31/343 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
  • A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
  • A61P 7/06 - Antianaemics
  • A61K 31/4184 - 1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles

3.

KL1333 FOR USE IN MEDICINE

      
Application Number 18561794
Status Pending
Filing Date 2022-05-19
First Publication Date 2024-07-18
Owner
  • ABLIVA AB (Sweden)
  • YUNGJIN PHARM. CO., LTD (Republic of Korea)
Inventor
  • Hansson, Magnus Joakim
  • Hugerth, Matilda
  • Grönberg, Alvar

Abstract

The present invention relates to i) KL1333 for use in the treatment of mitochondrial diseases or diseases associated with mitochodrial diseases such as fatigue such as fatigue syndrome and fatigue associated with a disease or muscle weakness associated with a mitochondrial disease, ii) KL1333 for use in a dosage regime for the treatment of one or more of fatigue, muscle weakness or a mitochondrial disease, iii) use of blood lactate (mM)/pyruvate (mM) ratio as biomarker of KL1333 treatment effect, wherein a decrease in ratio indicates that the treatment is effective, and iv) use of serum niacinamide and/or xanthine as biomarker of KL1333 treatment effect, wherein an increase in the ratio of niacinamide and/or xanthine concentrations indicates that the treatment is effective and the ratio of niacinamide and/or xanthine concentrations is (serum concentration at test day)/(serum concentration at the start of the treatment).

IPC Classes  ?

  • A61K 31/4184 - 1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
  • A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system

4.

Succinate prodrug, compositions containing the succinate prodrug and uses thereof

      
Application Number 17944751
Grant Number 12162824
Status In Force
Filing Date 2022-09-14
First Publication Date 2023-02-02
Grant Date 2024-12-10
Owner ABLIVA AB (Sweden)
Inventor
  • Hansson, Magnus Joakim
  • Grönberg, Alvar
  • Elmér, Mats Eskil
  • Farmery, Mark Richard
  • Moss, Steven James
  • Webster, Lee Robert
  • Gregory, Matthew Alan

Abstract

The present invention provides a novel isolated succinate prodrug as the free compound or a salt, hydrate, solvate or complex thereof being cell permeable and aimed for increasing the ATP-production in mitochondria. The compound is useful in the medical treatment of a range of diseases, in nutritional supplements, nutricosmetics and in cosmetics.

IPC Classes  ?

  • C07C 327/30 - Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
  • A61P 3/00 - Drugs for disorders of the metabolism

5.

KL1333 FOR USE IN MEDICINE

      
Document Number 03218015
Status Pending
Filing Date 2022-05-19
Open to Public Date 2022-11-24
Owner
  • ABLIVA AB (Sweden)
  • YUNGJIN PHARM CO., LTD (Republic of Korea)
Inventor
  • Hansson, Magnus Joakim
  • Hugerth, Matilda
  • Gronberg, Alvar

Abstract

The present invention relates to i) KL1333 for use in the treatment of mitochondrial diseases or diseases associated with mitochodrial diseases such as fatigue such as fatigue syndrome and fatigue associated with a disease or muscle weakness associated with a mitochondrial disease, ii) KL1333 for use in a dosage regime for the treatment of one or more of fatigue, muscle weakness or a mitochondrial disease, iii) use of blood lactate (mM)Zpyruvate (mM) ratio as biomarker of KL1333 treatment effect, wherein a decrease in ratio indicates that the treatment is effective, and iv) use of serum niacinamide and/or xanthine as biomarker of KL1333 treatment effect, wherein an increase in the ratio of niacinamide and/or xanthine concentrations indicates that the treatment is effective and the ratio of niacinamide and/or xanthine concentrations is (serum concentration at test day)/(serum concentration at the start of the treatment).

IPC Classes  ?

  • A61K 31/4184 - 1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
  • A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
  • A61P 43/00 - Drugs for specific purposes, not provided for in groups

6.

KL1333 FOR USE IN MEDICINE

      
Application Number EP2022063583
Publication Number 2022/243435
Status In Force
Filing Date 2022-05-19
Publication Date 2022-11-24
Owner
  • ABLIVA AB (Sweden)
  • YUNGJIN PHARM CO., LTD (Republic of Korea)
Inventor
  • Hansson, Magnus Joakim
  • Hugerth, Matilda
  • Grönberg, Alvar

Abstract

The present invention relates to i) KL1333 for use in the treatment of mitochondrial diseases or diseases associated with mitochodrial diseases such as fatigue such as fatigue syndrome and fatigue associated with a disease or muscle weakness associated with a mitochondrial disease, ii) KL1333 for use in a dosage regime for the treatment of one or more of fatigue, muscle weakness or a mitochondrial disease, iii) use of blood lactate (mM)Zpyruvate (mM) ratio as biomarker of KL1333 treatment effect, wherein a decrease in ratio indicates that the treatment is effective, and iv) use of serum niacinamide and/or xanthine as biomarker of KL1333 treatment effect, wherein an increase in the ratio of niacinamide and/or xanthine concentrations indicates that the treatment is effective and the ratio of niacinamide and/or xanthine concentrations is (serum concentration at test day)/(serum concentration at the start of the treatment).

IPC Classes  ?

  • A61K 31/4184 - 1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
  • A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
  • A61P 43/00 - Drugs for specific purposes, not provided for in groups

7.

Succinate prodrug, compositions containing the succinate prodrug and uses thereof

      
Application Number 17615408
Grant Number 11565998
Status In Force
Filing Date 2020-06-18
First Publication Date 2022-05-26
Grant Date 2023-01-31
Owner ABLIVA AB (Sweden)
Inventor
  • Hansson, Magnus Joakim
  • Grönberg, Alvar
  • Elmér, Mats Eskil
  • Farmery, Mark Richard
  • Moss, Steven James
  • Webster, Lee Robert
  • Gregory, Matthew Alan

Abstract

The present invention provides a novel isolated succinate prodrug as the free com-pound or a salt, hydrate, solvate or complex thereof being cell permeable and aimed for increasing the ATP-production in mitochondria. The compound is useful in the medical treatment of a range of diseases, in nutritional supplements, nutricosmetics and in cosmetics.

IPC Classes  ?

  • C07C 327/30 - Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
  • A61P 3/00 - Drugs for disorders of the metabolism

8.

NOVEL CELL-PERMEABLE SUCCINATE COMPOUNDS

      
Application Number 17474482
Status Pending
Filing Date 2021-09-14
First Publication Date 2021-12-30
Owner ABLIVA AB (Sweden)
Inventor
  • Elmer, Eskil
  • Hansson, Magnus Joakim
  • Ehinger, Karl Henrik Johannes
  • Moss, Steven

Abstract

The present invention provides novel cell-permeable succinates and cell permeable precursors of succinate aimed at increasing ATP-production in mitochondria. The main part of ATP produced and utilized in the eukaryotic cell originates from mitochondrial oxidative phosphorylation, a process to which high-energy electrons are provided by the Kreb's cycle. Not all Kreb's cycle intermediates are readily permeable to the cellular membrane, one of them being succinate. The provision of the novel cell permeable succinates is envisaged to allow passage over the cellular membrane and thus the cell permeable succinates can be used to enhance mitochondrial ATP-output.

IPC Classes  ?

  • A61K 31/265 - Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
  • A61K 31/155 - Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (HN=C(OH)NH2), isothiourea (HN=C(SH)—NH2)
  • A61K 31/22 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
  • C07D 211/76 - Oxygen atoms attached in position 2 or 6
  • A61P 11/00 - Drugs for disorders of the respiratory system
  • A61P 9/00 - Drugs for disorders of the cardiovascular system
  • A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • C07C 327/28 - Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
  • C07C 327/30 - Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
  • C07C 327/32 - Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
  • C07C 327/34 - Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups with amino groups bound to the same hydrocarbon radicals

9.

SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF

      
Document Number 03143112
Status Pending
Filing Date 2020-06-18
Open to Public Date 2020-12-24
Owner ABLIVA AB (Sweden)
Inventor
  • Hansson, Magnus Joakim
  • Gronberg, Alvar
  • Elmer, Mats Eskil
  • Farmery, Mark Richard
  • Moss, Steven James
  • Webster, Lee Robert
  • Gregory, Matthew Alan

Abstract

The present invention provides a novel isolated succinate prodrug as the free com- pound or a salt, hydrate, solvate or complex thereof being cell permeable and aimed for increasing the ATP-production in mitochondria. The compound is useful in the medical treatment of a range of diseases, in nutritional supplements, nutricosmetics and in cosmetics.

IPC Classes  ?

  • C07C 327/30 - Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
  • A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives
  • A23L 2/52 - Adding ingredients
  • A61K 8/46 - Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
  • A61K 31/265 - Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid

10.

SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF

      
Application Number EP2020066923
Publication Number 2020/254484
Status In Force
Filing Date 2020-06-18
Publication Date 2020-12-24
Owner ABLIVA AB (Sweden)
Inventor
  • Hansson, Magnus Joakim
  • Grönberg, Alvar
  • Elmér, Mats Eskil
  • Farmery, Mark Richard
  • Moss, Steven James
  • Webster, Lee Robert
  • Gregory, Matthew Alan

Abstract

The present invention provides a novel isolated succinate prodrug as the free com- pound or a salt, hydrate, solvate or complex thereof being cell permeable and aimed for increasing the ATP-production in mitochondria. The compound is useful in the medical treatment of a range of diseases, in nutritional supplements, nutricosmetics and in cosmetics.

IPC Classes  ?

  • C07C 327/30 - Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
  • A61K 31/16 - Amides, e.g. hydroxamic acids
  • A61P 3/00 - Drugs for disorders of the metabolism

11.

ABLIVA

      
Application Number 1549997
Status Registered
Filing Date 2020-07-15
Registration Date 2020-07-15
Owner Abliva AB (Sweden)
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

Medical research; research relating to biotechnology; clinical research; conducting clinical trials for pharmaceutical products.

12.

ABLIVA

      
Application Number 205210900
Status Registered
Filing Date 2020-07-15
Registration Date 2023-05-24
Owner Abliva AB (Sweden)
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

(1) Medical research; research in the field of biotechnology; research in the field of genetic engineering; pharmaceutical research services; research in the field of pharmaceutical development; conducting observational clinical research; conducting interventional clinical studies; conducting clinical trials for pharmaceutical products.

13.

ABLIVA

      
Serial Number 79293512
Status Registered
Filing Date 2020-07-15
Registration Date 2021-09-07
Owner Abliva AB (Sweden)
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

Medical research; research relating to biotechnology; clinical research in the field of mitochondrial diseases; conducting clinical trials for pharmaceutical products for others

14.

ABLIVA

      
Application Number 018190851
Status Registered
Filing Date 2020-01-31
Registration Date 2020-05-22
Owner Abliva AB (Sweden)
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

Medical research; Research relating to biotechnology; Clinical research; Conducting clinical trials for pharmaceutical products.

15.

CAVATIA

      
Application Number 018190855
Status Registered
Filing Date 2020-01-31
Registration Date 2020-05-22
Owner Abliva AB (Sweden)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Chemical preparations for pharmaceutical purposes; Medicines for human purposes; Pharmaceutical drugs; Pharmaceuticals; Pharmaceutical preparations for human use. Medical research; Research relating to biotechnology; Clinical research; Conducting clinical trials for pharmaceutical products.

16.

Use of sanglifehrin macrocyclic analogues as anticancer compounds

      
Application Number 16349757
Grant Number 10857150
Status In Force
Filing Date 2017-11-17
First Publication Date 2019-10-31
Grant Date 2020-12-08
Owner ABLIVA AB (Sweden)
Inventor
  • Gronberg, Alvar
  • Hansson, Magnus Joakim
  • Gregory, Matthew Alan
  • Moss, Steven James

Abstract

The present invention relates to sanglifehrin macrocyclic analogues according to Formula (I), particularly for use in treatment of cancer, especially liver cancer.

IPC Classes  ?

  • C07D 498/08 - Bridged systems
  • A61K 31/50 - PyridazinesHydrogenated pyridazines
  • A61K 31/44 - Non-condensed pyridinesHydrogenated derivatives thereof
  • A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin
  • A61K 39/395 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum
  • C07D 237/04 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members

17.

NP

      
Application Number 1465857
Status Registered
Filing Date 2018-11-09
Registration Date 2018-11-09
Owner Abliva AB (Sweden)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Esters for veterinary use; esters for veterinary purposes; esters for foodstuffs, not for pharmaceutical purposes. Acetates for pharmaceutical purposes; acids for pharmaceutical purposes; adjuvants for medical purposes; aldehydes for pharmaceutical purposes; alginates for pharmaceutical purposes; amino acids for medical purposes; amino acids for veterinary purposes; antibiotics; antidiabetic pharmaceuticals; antioxidant pills; antioxidants; antitumor drugs; appetite suppressant pills; appetite suppressants; appetite suppressants for medical purposes; appetite suppressants for veterinary purposes; bacterial preparations for medical use; bacterial preparations for veterinary use; bacteriological culture mediums; bacteriological preparations for medical purposes; bacteriological preparations for medical use; bacteriological preparations for veterinary purposes; bacteriological preparations for veterinary use; biological preparations for medical purposes; biological preparations for the treatment of cancer; biological preparations for veterinary purposes; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological tissues for implantation; bouillons for bacteriological cultures; cachets for pharmaceutical preparations; cachets for veterinary preparations; capsules for medicines; castor oil for medical purposes; cellulose ethers for pharmaceutical purposes; chemical preparations for medical purposes; chemical preparations for pharmaceutical purposes; chemical preparations for veterinary purposes; chemico-pharmaceutical preparations; cytostatic drugs for medical purposes; decoctions of medicinal herb; decoctions for pharmaceutical purposes; dental wax; diagnostic biomarker reagents for medical purposes; diagnostic biomarker reagents for veterinary purposes; diagnostic preparations; diagnostic preparations for medical use; diagnostic preparations for veterinary use; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic radiopharmaceutical preparations; dietary supplements for animals; dietary supplements for humans; dietetic food and substances adapted for medical or veterinary use, food for babies; dietetic food and substances adapted for medical or veterinary use; dietetic substances adapted for medical use, food for babies; digestive enzymes; disinfectants; drugs for medical purposes; elixirs [pharmaceutical preparations]; enzyme dietary supplements; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; enzymes for medical purposes; enzymes for veterinary purposes; esters for pharmaceutical use; ethers for pharmaceutical purposes; ferments for pharmaceutical purposes; ferments for pharmaceutical use; ferments for veterinary purposes; ferments for veterinary use; food esters for pharmaceutical purposes; formic aldehyde for pharmaceutical purposes; formic aldehyde for veterinary purposes; fungicides, herbicides; in vitro diagnostic preparations for medical use; lotions for medical purposes; lotions for pharmaceutical purposes; lotions for veterinary purposes; material for stopping teeth; material for stopping teeth, dental wax; media for bacteriological cultures; medical and veterinary preparations and articles; medical preparations; medical preparations for slimming purposes; medical vaccines; medicated animal feed; medicinal drinks; medicinal infusions; medicinal oils; medicines and pharmaceutical preparations for neurosurgical conditions, brain damage, operations and similar; medicines and pharmaceutical preparations for neurosurgical conditions, brain damage and brain operations; medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, brain damage, brain operations and other physical and neurological ailments of the brain; medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, namely, for brain damage and for use in brain operations and other physical and neurological ailments of the brain; medicines and pharmaceutical preparations for use as immunosuppressive agents, for example for organ transplant or other medical (and clinical) uses of immunosuppressive agents or preparations; medicines and pharmaceutical preparations for use as immunosuppressive agents in organ transplants or other medical and clinical uses of immunosuppressive agents and preparations; medicines and pharmaceutical preparations for use as immunosuppressive agents, for example organ transplant or other uses of immunosuppressive agents; medicines and pharmaceutical preparations for use within the area of neurological intensive care; medicines for animals; medicines for human purposes; medicines for veterinary purposes; mixed biological preparations for medical purposes; mixed biological preparations for veterinary purposes; nutritional supplements; nutritional supplements for livestock feed; ointments for medical purposes; pharmaceutical and veterinary preparations; pharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for the treatment and prevention of acute and chronic neurological illnesses and conditions; pharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for acute and chronic neurological illnesses and conditions and for preventative treatment; pharmaceutical drugs; pharmaceutical preparations; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides; pharmaceutical preparations and substances; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for animals; pharmaceutical preparations for human use; pharmaceutical preparations for medical purposes and veterinary purposes; pharmaceutical preparations for medical use consisting of a cyclosporin as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions; pharmaceutical preparations for medical use consisting of a cyclosporin or another cyclophilin inhibitor as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions; pharmaceutical preparations for skin care; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the prevention of diseases of the nervous system; pharmaceutical preparations for the prevention of diseases of the metabolic system; pharmaceutical preparations for the prevention of disorders of the metabolic system; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for the prevention of tumours; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of central nervous system [cns] diseases; pharmaceutical preparations for the treatment of diseases caused by bacteria; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of disorders of the metabolic system; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of parkinson's disease; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating heatstroke; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for use as immunosuppressive agents; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in organ transplantation; pharmaceutical preparations for use in tissue transplantation; pharmaceutical preparations for use within the area of neurological intensive care; pharmaceutical preparations for veterinary use; pharmaceuticals; pharmaceuticals, medical and veterinary preparations; phosphates for pharmaceutical purposes; phosphates for veterinary purposes; plasters, materials for dressings; potassium salts for medical purposes; potassium salts for veterinary purposes; preparations for destroying vermin; quinine for medical purposes; quinine for veterinary purposes; salts for medical purposes; salts for veterinary purposes; sanitary preparations for medical purposes; sanitary preparations for veterinary purposes; slimming pills; sodium salts for medical purposes; sodium salts for veterinary purposes; sulfonamides [medicines]; tinctures for medical purposes; tinctures for veterinary purposes; tonics [medicines]; tonics for medical use; tonics for veterinary use; vaccines; vaccines for human use; veterinary preparations; veterinary preparations and substances; veterinary vaccines; drugs and pharmaceutical preparations for acute and chronic neurological diseases and conditions (including preventive treatment); diagnostic agents, preparations and substances for medical purposes. Apparatus and instruments for measuring, testing and analyzing biological samples, blood or other bodily fluids; chromatography apparatus for laboratory use; diagnostic apparatus, not for medical purposes; DNA chips; laboratory apparatus and instruments; quantity indicators; respirometers; scientific research and laboratory apparatus, educational apparatus and simulators; chemistry apparatus and instruments; electrodes for laboratory research. Apparatus for analyzing substances [for medical use]; apparatus for blood tests [for medical use]; apparatus for use in medical analysis; blood testing apparatus; blood testing equipment; electrodes for medical use; analytical apparatus for medical purposes; medical apparatus and instruments; diagnostic apparatus for medical purposes; medical diagnostic instruments; probes for medical purposes; probes for veterinary purposes; medical electrodes; electrodes for use in connection with medical apparatus; electrodes for cardiology; electrodes for veterinary use, namely medical electrodes. Analysis of human tissues for medical research; bacteriological analysis and consultation; biochemical research; biological analysis; biological laboratory services; biological research and analysis; biological research, clinical research and medical research; biological sample analysis for scientific and medical research purposes; biological samples, blood or other bodily fluids analysis services for scientific and medical research purposes; biotechnology research; blood analysis services; blood analysis services for scientific and medical research purposes; chemical analysis and research; chemical research and analysis services; chemistry consultancy services; clinical research; clinical research and trials; clinical trials; conducting clinical trials; conducting clinical trials for others; conducting clinical trials for pharmaceutical products; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of cosmetics, namely, consultancy in connection with the quality inspection, research and development of cosmetic products and medicated cosmetic products; consultancy in the field of sanitary research for medical purpose; consultancy in the fields of pharmaceutical, pharmacogenetics, medical chemistry, veterinary, for research purposes; consultancy services in the field of biology; consultancy services in the field of biotechnology; consultancy relating to research in the field of pharmacogenetics; cosmetic research; cosmetic research and scientific analysis services; cosmetic research services and laboratory analysis services in the field of cosmetics; design and development of computer hardware and software; design and development of diagnostic apparatus and instruments; design and development of medical diagnostic apparatus and instruments; development, testing and consultancy services in the fields of biotechnology, pharmacy, medicine, sanitation, veterinary medicine, chemistry, biology and pharmacogenetics; DNA analysis for scientific and medical research purposes; drug and pharmaceutical discovery, testing and development services; drug discovery services; industrial analysis and research services; laboratory research services relating to pharmaceuticals; medical and veterinary research and development and consultancy related thereto; medical laboratory services; medical research; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services; providing information in connection with all the aforementioned services; providing medical and veterinary testing services in the field of research relating to medicines, drug discovery, drug development and drug screening and consultancy related thereto; research and development in the field of biotechnology; research and development in the field of microorganisms and cells; research and development in the pharmaceutical and biotechnology fields; research and development services; research and testing; research of pharmaceuticals; research relating to biotechnology; research relating to pharmaceuticals; research, development and testing services and consultancy related thereto, in the fields of biotechnology, pharmacy, medicine, sanitation, veterinary medicine, chemistry, biology and pharmacogenetics; research, development, and testing services, and consultancy related thereto, in the fields of biotechnology, pharmaceuticals, sanitary products, chemistry, biology and pharmacogenetics; research, development, testing and consultancy services in the fields of biotechnology, pharmacy, medicine, sanitation, veterinary medicine, chemistry, biology and pharmacogenetics; research, development, testing, scientific consultancy services in the fields of biotechnology, pharmacy, medicine, sanitation, veterinary medicine, chemistry, biology and pharmacogenetics; research in the field of environmental protection; research, test and development of sanitary, pharmaceutical, medical, medicinal chemical, veterinary preparations; research, test and development of biotechnical, biological preparations; research, testing and development in the field of diagnostic preparations; research, testing and development in the field of diagnostic preparations; research, testing and development of diagnostic preparations for medical purpose; scientific analysis; scientific and technological services and research and design relating thereto; scientific laboratory services; scientific research; scientific research relating to cosmetics; testing of pharmaceuticals; toxicity analysis; toxicity testing for research purposes; veterinary laboratory services. Agriculture, horticulture and forestry service; analysis of human serum for medical treatment; analysis of human tissues for medical treatment; "consultancy in the dental care field; consultancy in the field of cosmetics; consultancy in the field of cosmetics, namely consultancy in connection with the selection of cosmetic products and medicated cosmetic products; consultancy in the field of pharmacogenetics; consultancy in the medical field (other than dentistry); drug screening for medical purposes; health care; health care services; hygienic and beauty care for human beings or animals; medical and surgical diagnostic services; medical and surgical diagnostic services; medical consultancy in the field of pharmacogenetics; medical consultancy services; medical diagnostic services; medical services; medical testing for diagnostic or treatment purposes; pharmaceutical consultancy services; providing information in connection with all the aforementioned services; rental of ultrasonic diagnostic apparatus; therapy services; veterinary consultancy services; veterinary services.

18.

NEUROVIVE

      
Application Number 1446626
Status Registered
Filing Date 2018-11-09
Registration Date 2018-11-09
Owner Abliva AB (Sweden)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Esters for veterinary use; esters for veterinary purposes; esters for foodstuffs, not for pharmaceutical purposes. Acetates for pharmaceutical purposes; acids for pharmaceutical purposes; adjuvants for medical purposes; aldehydes for pharmaceutical purposes; alginates for pharmaceutical purposes; amino acids for medical purposes; amino acids for veterinary purposes; antibiotics; antidiabetic pharmaceuticals; antioxidant pills; antioxidants; antitumor drugs; appetite suppressant pills; appetite suppressants; appetite suppressants for medical purposes; appetite suppressants for veterinary purposes; bacterial preparations for medical use; bacterial preparations for veterinary use; bacteriological culture mediums; bacteriological preparations for medical purposes; bacteriological preparations for medical use; bacteriological preparations for veterinary purposes; bacteriological preparations for veterinary use; biological preparations for medical purposes; biological preparations for the treatment of cancer; biological preparations for veterinary purposes; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological tissues for implantation; bouillons for bacteriological cultures; cachets for pharmaceutical preparations; cachets for veterinary preparations; capsules for medicines; castor oil for medical purposes; cellulose ethers for pharmaceutical purposes; chemical preparations for medical purposes; chemical preparations for pharmaceutical purposes; chemical preparations for veterinary purposes; chemicopharmaceutical preparations; cytostatic drugs for medical purposes; decoctions for medicinal herb; decoctions for pharmaceutical purposes; dental wax; diagnostic biomarker reagents for medical purposes; diagnostic biomarker reagents for veterinary purposes; diagnostic preparations; diagnostic preparations for medical use; diagnostic preparations for veterinary use; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic radiopharmaceutical preparations; dietary supplements for animals; dietary supplements for humans; dietetic food and substances adapted for medical or veterinary use, food for babies; dietetic food and substances adapted for medical or veterinary use; dietetic substances adapted for medical use, food for babies; digestive enzymes; disinfectants; drugs for medical purposes; elixirs [pharmaceutical preparations]; enzyme dietary supplements; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; enzymes for medical purposes; enzymes for veterinary purposes; esters for pharmaceutical use; ethers for pharmaceutical purposes; ferments for pharmaceutical purposes; ferments for pharmaceutical use; ferments for veterinary purposes; ferments for veterinary use; food esters for pharmaceutical purposes; formic aldehyde for pharmaceutical purposes; formic aldehyde for veterinary purposes; fungicides, herbicides; in vitro diagnostic preparations for medical use; lotions for medical purposes; lotions for pharmaceutical purposes; lotions for veterinary purposes; material for stopping teeth; material for stopping teeth, dental wax; media for bacteriological cultures; medical and veterinary preparations and articles; medical preparations; medical preparations for slimming purposes; medical vaccines; medicated animal feed; medicinal drinks; medicinal infusions; medicinal oils; medicines and pharmaceutical preparations for neurosurgical conditions, brain damage, operations and similar; medicines and pharmaceutical preparations for neurosurgical conditions, brain damage and brain operations; medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, brain damage, brain operations and other physical and neurological ailments of the brain; medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, namely, for brain damage and for use in brain operations and other physical and neurological ailments of the brain; medicines and pharmaceutical preparations for use as immunosuppressive agents, for example for organ transplant or other medical (and clinical) uses of immunosuppressive agents or preparations; medicines and pharmaceutical preparations for use as immunosuppressive agents in organ transplants or other medical and clinical uses of immunosuppressive agents and preparations; medicines and pharmaceutical preparations for use as immunosuppressive agents, for example organ transplant or other uses of immunosuppressive agents; medicines and pharmaceutical preparations for use within the area of neurological intensive care; medicines for animals; medicines for human purposes; medicines for veterinary purposes; mixed biological preparations for medical purposes; mixed biological preparations for veterinary purposes; nutritional supplements; nutritional supplements for livestock feed; ointments for medical purposes; pharmaceutical and veterinary preparations; pharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for the treatment and prevention of acute and chronic neurological illnesses and conditions; pharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for acute and chronic neurological illnesses and conditions and for preventative treatment; pharmaceutical drugs; pharmaceutical preparations; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides; pharmaceutical preparations and substances; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for animals; pharmaceutical preparations for human use; pharmaceutical preparations for medical purposes and veterinary purposes; pharmaceutical preparations for medical use consisting of a cyclosporin as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions; pharmaceutical preparations for medical use consisting of a cyclosporin or another cyclophilin inhibitor as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions; pharmaceutical preparations for skin care; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the prevention of diseases of the nervous system; pharmaceutical preparations for the prevention of diseases of the metabolic system; pharmaceutical preparations for the prevention of disorders of the metabolic system; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for the prevention of tumours; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of central nervous system [cns] diseases; pharmaceutical preparations for the treatment of diseases caused by bacteria; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of disorders of the metabolic system; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of parkinson's disease; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating heatstroke; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for use as immunosuppressive agents; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in organ transplantation; pharmaceutical preparations for use in tissue transplantation; pharmaceutical preparations for use within the area of neurological intensive care; pharmaceutical preparations for veterinary use; pharmaceuticals; pharmaceuticals, medical and veterinary preparations; phosphates for pharmaceutical purposes; phosphates for veterinary purposes; plasters, materials for dressings; potassium salts for medical purposes; potassium salts for veterinary purposes; preparations for destroying vermin; quinine for medical purposes; quinine for veterinary purposes; salts for medical purposes; salts for veterinary purposes; sanitary preparations for medical purposes; sanitary preparations for veterinary purposes; slimming pills; sodium salts for medical purposes; sodium salts for veterinary purposes; sulfonamides [medicines]; tinctures for medical purposes; tinctures for veterinary purposes; tonics [medicines]; tonics for medical use; tonics for veterinary use; vaccines; vaccines for human use; veterinary preparations; veterinary preparations and substances; veterinary vaccines; drugs and pharmaceutical preparations for acute and chronic neurological diseases and conditions (including preventive treatment); diagnostics for medical purposes. Apparatus and instruments for measuring, testing and analyzing biological samples, blood or other bodily fluids; chromatography apparatus for laboratory use; diagnostic apparatus, not for medical purposes; DNA chips; laboratory apparatus and instruments; quantity indicators respirometer; scientific research and laboratory apparatus, educational apparatus and simulators; chemical apparatus and instruments; electrodes for laboratory research. Apparatus for analyzing substances [for medical use]; apparatus for blood tests [for medical use]; apparatus for use in medical analysis; blood testing apparatus; blood testing equipment; electrodes for medical use; medical analytical apparatus for medical purposes; medical apparatus and instruments; medical diagnostic apparatus for medical purposes; medical diagnostic instruments; probes for medical purposes; probes for veterinary purposes; medical electrodes; electrodes for use in connection with medical apparatus; electrodes for cardiology; electrodes for veterinary use, namely medical electrodes. Analysis of human tissues for medical research; bacteriological analysism, consultation; biochemical research; biological analysis; biological laboratory services; biological research and analysis; biological research, clinical research and medical research; biological sample analysis for scientific and medical research purposes; biological samples, blood or other bodily fluids analysis services for scientific and medical research purposes; biotechnology research; blood analysis services; blood analysis services for scientific and medical re-search purposes; chemical analysis and research; chemical research and analysis ser-vices; chemistry consultancy services; clinical research; clinical research and trials; clinical trials; conducting clinical trials; conducting clinical trials for others; conducting clinical trials for pharmaceutical products; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of cosmetics, namely, consultancy in connection with the quality inspection, research and development of cosmetic products and medicated cosmetic products; consultancy in the field of sanitary research for medical purpose; consultancy in pharmaceutical, pharmacogenetics, medical chemistry, veterinary, for research purposes; consultancy services in the field of biology; consultancy services in the field of biotechnology; consulting on pharmacogenetics; cosmetic research; cosmetic research and analysis services; cosmetic research services and laboratory analysis services in the field of cosmetics; design and development of computer hardware and software; design and development of diagnostic apparatus and instruments; design and development of medical diagnostic apparatus and instruments; development, testing and consultancy services in the fields of biotechnology, pharmaceutical, medical, sanitary, veterinary, chemistry, biology and pharmacogenetics; dna analysis for scientific and medical research purposes; drug and pharmaceutical discovery, testing and development services; drug discovery services; industrial analysis and research services; laboratory research services relating to pharmaceuticals; medical and veterinary research and development and consultancy related there-to; medical laboratory services; medical research; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services; providing information in connection with all the aforementioned services; providing medical and veterinary testing services in the field of research relating to medicines, drug discovery, drug development and drug screening and consultancy related thereto; research and development in the field of biotechnology; research and development in the field of microorganisms and cells; research and development in the pharmaceutical and biotechnology fields; research and development services; research and testing; research of pharmaceuticals; research relating to biotechnology; research relating to pharmaceuticals; research, development, and testing services, and consultancy related thereto, in the fields of biotechnology, pharmaceutical, medical, sanitary, veterinary, chemistry, biology and pharmacogenetics; research, development, and testing services, and consultancy related thereto, in the fields of biotechnology, pharmaceuticals, sanitary products, chemistry, biology and pharmacogenetics; research, development, testing and consultancy services in the fields of biotechnology, pharmaceutical, medical, sanitary, veterinary, chemistry, biology and pharmacogenetics; research, development, testing, scientific consultancy services in the fields of biotechnology, pharmaceutical, medical, sanitary, veterinary, chemistry, biology and pharmacogenetics; research, research in the field of environmental protection; re-search, test and development of sanitary, pharmaceutical, medical, medicinal chemical, veterinary preparations; research, test and development of biotechnical, biological preparations; research, testing and development in the field of diagnostic preparations; research, testing and development in the field of diagnostic preparations; research, testing and development of diagnostic preparations for medical purpose; scientific analysis; scientific and technological services and research and design relating thereto; scientific laboratory ser-vices; scientific research; scientific research relating to cosmetics; testing of pharmaceuticals; toxicity analysis; toxicity testing for research purposes; veterinary laboratory services. Agriculture, horticulture and forestry service; analysis of human serum for medical treatment; analysis of human tissues for medical treatment; consultancy in the dental medicare field; consultancy in the field of cosmetics; consultancy in the field of cosmetics, namely consultancy in connection with the selection of cosmetic products and medicated cosmetic products; consultancy in the field of pharmacogenetics; consultancy in the medical field (other than dentistry); drug screening for medical purposes; health care; health care services; hygienic and beauty care for human beings or animals; medical and surgical diagnostic services; medical and surgical diagnostic services; medical consultancy in the field of pharmacogenetics; medical consultancy services; medical diagnostic services; medical services; medical testing for diagnostic or treatment purposes; pharmaceutical consultancy services; providing information in connection with all the aforementioned services; rental of ultrasonic diagnostic apparatus; therapy services; veterinary consultancy services; veterinary services.

19.

NP NeuroVive PHARMACEUTICAL

      
Application Number 1447471
Status Registered
Filing Date 2018-11-09
Registration Date 2018-11-09
Owner Abliva AB (Sweden)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Esters for veterinary use; esters for veterinary purposes; esters for foodstuffs, not for pharmaceutical purposes. Acetates for pharmaceutical purposes; acids for pharmaceutical purposes; adjuvants for medical purposes; aldehydes for pharmaceutical purposes; alginates for pharmaceutical purposes; amino acids for medical purposes; amino acids for veterinary purposes; antibiotics; antidiabetic pharmaceuticals; antioxidant pills; antioxidants; antitumor drugs; appetite suppressant pills; appetite suppressants; appetite suppressants for medical purposes; appetite suppressants for veterinary purposes; bacterial preparations for medical use; bacterial preparations for veterinary use; bacteriological culture mediums; bacteriological preparations for medical purposes; bacteriological preparations for medical use; bacteriological preparations for veterinary purposes; bacteriological preparations for veterinary use; biological preparations for medical purposes; biological preparations for the treatment of cancer; biological preparations for veterinary purposes; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological tissues for implantation; bouillons for bacteriological cultures; cachets for pharmaceutical preparations; cachets for veterinary preparations; capsules for medicines; castor oil for medical purposes; cellulose ethers for pharmaceutical purposes; chemical preparations for medical purposes; chemical preparations for pharmaceutical purposes; chemical preparations for veterinary purposes; chemicopharmaceutical preparations; cytostatic drugs for medical purposes; decoctions for medicinal herb; decoctions for pharmaceutical purposes; dental wax; diagnostic biomarker reagents for medical purposes; diagnostic biomarker reagents for veterinary purposes; diagnostic preparations; diagnostic preparations for medical use; diagnostic preparations for veterinary use; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic radiopharmaceutical preparations; dietary supplements for animals; dietary supplements for humans; dietetic food and substances adapted for medical or veterinary use, food for babies; dietetic food and substances adapted for medical or veterinary use; dietetic substances adapted for medical use, food for babies; digestive enzymes; disinfectants; drugs for medical purposes; elixirs [pharmaceutical preparations]; enzyme dietary supplements; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; enzymes for medical purposes; enzymes for veterinary purposes; esters for pharmaceutical use; ethers for pharmaceutical purposes; ferments for pharmaceutical purposes; ferments for pharmaceutical use; ferments for veterinary purposes; ferments for veterinary use; food esters for pharmaceutical purposes; formic aldehyde for pharmaceutical purposes; formic aldehyde for veterinary purposes; fungicides, herbicides; in vitro diagnostic preparations for medical use; lotions for medical purposes; lotions for pharmaceutical purposes; lotions for veterinary purposes; material for stopping teeth; material for stopping teeth, dental wax; media for bacteriological cultures; medical and veterinary preparations and articles; medical preparations; medical preparations for slimming purposes; medical vaccines; medicated animal feed; medicinal drinks; medicinal infusions; medicinal oils; medicines and pharmaceutical preparations for neurosurgical conditions, brain damage, operations and similar; medicines and pharmaceutical preparations for neurosurgical conditions, brain damage and brain operations; medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, brain damage, brain operations and other physical and neurological ailments of the brain; medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, namely, for brain damage and for use in brain operations and other physical and neurological ailments of the brain; medicines and pharmaceutical preparations for use as immunosuppressive agents, for example for organ transplant or other medical (and clinical) uses of immunosuppressive agents or preparations; medicines and pharmaceutical preparations for use as immunosuppressive agents in organ transplants or other medical and clinical uses of immunosuppressive agents and preparations; medicines and pharmaceutical preparations for use as immunosuppressive agents, for example organ transplant or other uses of immunosuppressive agents; medicines and pharmaceutical preparations for use within the area of neurological intensive care; medicines for animals; medicines for human purposes; medicines for veterinary purposes; mixed biological preparations for medical purposes; mixed biological preparations for veterinary purposes; nutritional supplements; nutritional supplements for livestock feed; ointments for medical purposes; pharmaceutical and veterinary preparations; pharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for the treatment and prevention of acute and chronic neurological illnesses and conditions; pharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for acute and chronic neurological illnesses and conditions and for preventative treatment; pharmaceutical drugs; pharmaceutical preparations; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides; pharmaceutical preparations and substances; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for animals; pharmaceutical preparations for human use; pharmaceutical preparations for medical purposes and veterinary purposes; pharmaceutical preparations for medical use consisting of a cyclosporin as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions; pharmaceutical preparations for medical use consisting of a cyclosporin or another cyclophilin inhibitor as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions; pharmaceutical preparations for skin care; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the prevention of diseases of the nervous system; pharmaceutical preparations for the prevention of diseases of the metabolic system; pharmaceutical preparations for the prevention of disorders of the metabolic system; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for the prevention of tumours; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of central nervous system [cns] diseases; pharmaceutical preparations for the treatment of diseases caused by bacteria; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of disorders of the metabolic system; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of parkinson's disease; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating heatstroke; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for use as immunosuppressive agents; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in organ transplantation; pharmaceutical preparations for use in tissue transplantation; pharmaceutical preparations for use within the area of neurological intensive care; pharmaceutical preparations for veterinary use; pharmaceuticals; pharmaceuticals, medical and veterinary preparations; phosphates for pharmaceutical purposes; phosphates for veterinary purposes; plasters, materials for dressings; potassium salts for medical purposes; potassium salts for veterinary purposes; preparations for destroying vermin; quinine for medical purposes; quinine for veterinary purposes; salts for medical purposes; salts for veterinary purposes; sanitary preparations for medical purposes; sanitary preparations for veterinary purposes; slimming pills; sodium salts for medical purposes; sodium salts for veterinary purposes; sulfonamides [medicines]; tinctures for medical purposes; tinctures for veterinary purposes; tonics [medicines]; tonics for medical use; tonics for veterinary use; vaccines; vaccines for human use; veterinary preparations; veterinary preparations and substances; veterinary vaccines; drugs and pharmaceutical preparations for acute and chronic neurological diseases and conditions (including preventive treatment); diagnostics for medical purposes. Apparatus and instruments for measuring, testing and analyzing biological samples, blood or other bodily fluids; chromatography apparatus for laboratory use; diagnostic apparatus, not for medical purposes; DNA chips; laboratory apparatus and instruments; quantity indicators respirometer; scientific research and laboratory apparatus, educational apparatus and simulators; chemical apparatus and instruments; electrodes for laboratory research. Apparatus for analyzing substances [for medical use]; apparatus for blood tests [for medical use]; apparatus for use in medical analysis; blood testing apparatus; blood testing equipment; electrodes for medical use; medical analytical apparatus for medical purposes; medical apparatus and instruments; medical diagnostic apparatus for medical purposes; medical diagnostic instruments; probes for medical purposes; probes for veterinary purposes; medical electrodes; electrodes for use in connection with medical apparatus; electrodes for cardiology; electrodes for veterinary use, namely medical electrodes. Analysis of human tissues for medical research; bacteriological analysism, consultation; biochemical research; biological analysis; biological laboratory services; biological research and analysis; biological research, clinical research and medical research; biological sample analysis for scientific and medical research purposes; biological samples, blood or other bodily fluids analysis services for scientific and medical research purposes; biotechnology research; blood analysis services; blood analysis services for scientific and medical re-search purposes; chemical analysis and research; chemical research and analysis ser-vices; chemistry consultancy services; clinical research; clinical research and trials; clinical trials; conducting clinical trials; conducting clinical trials for others; conducting clinical trials for pharmaceutical products; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of cosmetics, namely, consultancy in connection with the quality inspection, research and development of cosmetic products and medicated cosmetic products; consultancy in the field of sanitary research for medical purpose; consultancy in pharmaceutical, pharmacogenetics, medical chemistry, veterinary, for research purposes; consultancy services in the field of biology; consultancy services in the field of biotechnology; consulting on pharmacogenetics; cosmetic research; cosmetic research and analysis services; cosmetic research services and laboratory analysis services in the field of cosmetics; design and development of computer hardware and software; design and development of diagnostic apparatus and instruments; design and development of medical diagnostic apparatus and instruments; development, testing and consultancy services in the fields of biotechnology, pharmaceutical, medical, sanitary, veterinary, chemistry, biology and pharmacogenetics; dna analysis for scientific and medical research purposes; drug and pharmaceutical discovery, testing and development services; drug discovery services; industrial analysis and research services; laboratory research services relating to pharmaceuticals; medical and veterinary research and development and consultancy related there-to; medical laboratory services; medical research; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services; providing information in connection with all the aforementioned services; providing medical and veterinary testing services in the field of research relating to medicines, drug discovery, drug development and drug screening and consultancy related thereto; research and development in the field of biotechnology; research and development in the field of microorganisms and cells; research and development in the pharmaceutical and biotechnology fields; research and development services; research and testing; research of pharmaceuticals; research relating to biotechnology; research relating to pharmaceuticals; research, development, and testing services, and consultancy related thereto, in the fields of biotechnology, pharmaceutical, medical, sanitary, veterinary, chemistry, biology and pharmacogenetics; research, development, and testing services, and consultancy related thereto, in the fields of biotechnology, pharmaceuticals, sanitary products, chemistry, biology and pharmacogenetics; research, development, testing and consultancy services in the fields of biotechnology, pharmaceutical, medical, sanitary, veterinary, chemistry, biology and pharmacogenetics; research, development, testing, scientific consultancy services in the fields of biotechnology, pharmaceutical, medical, sanitary, veterinary, chemistry, biology and pharmacogenetics; research, research in the field of environmental protection; re-search, test and development of sanitary, pharmaceutical, medical, medicinal chemical, veterinary preparations; research, test and development of biotechnical, biological preparations; research, testing and development in the field of diagnostic preparations; research, testing and development in the field of diagnostic preparations; research, testing and development of diagnostic preparations for medical purpose; scientific analysis; scientific and technological services and research and design relating thereto; scientific laboratory ser-vices; scientific research; scientific research relating to cosmetics; testing of pharmaceuticals; toxicity analysis; toxicity testing for research purposes; veterinary laboratory services. Agriculture, horticulture and forestry service; analysis of human serum for medical treatment; analysis of human tissues for medical treatment; consultancy in the dental medicare field; consultancy in the field of cosmetics; consultancy in the field of cosmetics, namely consultancy in connection with the selection of cosmetic products and medicated cosmetic products; consultancy in the field of pharmacogenetics; consultancy in the medical field (other than dentistry); drug screening for medical purposes; health care; health care services; hygienic and beauty care for human beings or animals; medical and surgical diagnostic services; medical and surgical diagnostic services; medical consultancy in the field of pharmacogenetics; medical consultancy services; medical diagnostic services; medical services; medical testing for diagnostic or treatment purposes; pharmaceutical consultancy services; providing information in connection with all the aforementioned services; rental of ultrasonic diagnostic apparatus; therapy services; veterinary consultancy services; veterinary services.

20.

NEUROVIVE

      
Application Number 017982039
Status Registered
Filing Date 2018-11-09
Registration Date 2021-08-17
Owner Abliva AB (Sweden)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

esters for foodstuffs, not for pharmaceutical purposes. Fungicides, herbicides; preparations for destroying vermin, fungicides, herbicides. Apparatus and instruments for measuring, testing and analyzing biological samples, blood or other bodily fluids, not for medical purposes; chromatography apparatus for laboratory use; diagnostic apparatus, not for medical purposes; DNA chips; laboratory apparatus and instruments; quantity indicators respirometer; scientific research and laboratory apparatus, educational apparatus and simulators; electrodes for laboratory research. Consultancy in the field of cosmetics, namely, consultancy in connection with the quality inspection, research and development of cosmetic products and medicated cosmetic products; Cosmetic research; Cosmetic research and analysis services; Cosmetic research services and laboratory analysis services in the field of cosmetics; Design and development of computer hardware and software; scientific research relating to cosmetics. Agriculture, horticulture and forestry service; consultancy in the field of cosmetics; consultancy in the field of cosmetics, namely consultancy in connection with the selection of cosmetic products and medicated cosmetic products; hygienic and beauty care for human beings or animals; providing information in connection with all the aforementioned services; rental of ultrasonic diagnostic apparatus; therapy services.

21.

NP

      
Application Number 017982041
Status Registered
Filing Date 2018-11-09
Registration Date 2019-06-08
Owner Abliva AB (Sweden)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

esters for foodstuffs, not for pharmaceutical purposes. Acetates for pharmaceutical purposes; acids for pharmaceutical purposes; adjuvants for medical purposes; aldehydes for pharmaceutical purposes; alginates for pharmaceutical purposes; amino acids for medical purposes; amino acids for veterinary purposes; antibiotics; Antidiabetic pharmaceuticals; antioxidant pills; antioxidants; Antitumor drugs; appetite suppressant pills; appetite suppressants; appetite suppressants for medical purposes; appetite suppressants for veterinary purposes; bacterial preparations for medical use; bacterial preparations for veterinary use; bacteriological culture mediums; bacteriological preparations for medical purposes; bacteriological preparations for medical use; bacteriological preparations for veterinary purposes; bacteriological preparations for veterinary use; Biological preparations for medical purposes; biological preparations for the treatment of cancer; biological preparations for veterinary purposes; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological tissues for implantation; bouillons for bacteriological cultures; cachets for pharmaceutical preparations; cachets for veterinary preparations; capsules for medicines; castor oil for medical purposes; cellulose ethers for pharmaceutical purposes; chemical preparations for medical purposes; Chemical preparations for pharmaceutical purposes; chemical preparations for veterinary purposes; chemicopharmaceutical preparations; Cytostatic drugs for medical purposes; decoctions for medicinal herb; decoctions for pharmaceutical purposes; Dental wax; diagnostic biomarker reagents for medical purposes; diagnostic biomarker reagents for veterinary purposes; diagnostic preparations; diagnostic preparations for medical use; diagnostic preparations for veterinary use; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic radiopharmaceutical preparations; dietary supplements for animals; dietary supplements for humans; Dietetic food and substances adapted for medical or veterinary use, food for babies; dietetic food and substances adapted for medical or veterinary use; Dietetic substances adapted for medical use, food for babies; Digestive enzymes; Disinfectants; drugs for medical purposes; elixirs [pharmaceutical preparations]; enzyme dietary supplements; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; enzymes for medical purposes; enzymes for veterinary purposes; esters for pharmaceutical use; ethers for pharmaceutical purposes; ferments for pharmaceutical purposes; ferments for pharmaceutical use; ferments for veterinary purposes; ferments for veterinary use; food esters for pharmaceutical purposes; formic aldehyde for pharmaceutical purposes; formic aldehyde for veterinary purposes; Fungicides, herbicides; in vitro diagnostic preparations for medical use; lotions for medical purposes; lotions for pharmaceutical purposes; lotions for veterinary purposes; Material for stopping teeth; Material for stopping teeth, dental wax; media for bacteriological cultures; Medical and veterinary preparations and articles; medical preparations; medical preparations for slimming purposes; medical vaccines; medicated animal feed; medicinal drinks; medicinal infusions; medicinal oils; Medicines and pharmaceutical preparations for neurosurgical conditions, brain damage, operations and similar; Medicines and pharmaceutical preparations for neurosurgical conditions, brain damage and brain operations; Medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, brain damage, brain operations and other physical and neurological ailments of the brain; Medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, namely, for brain damage and for use in brain operations and other physical and neurological ailments of the brain; Medicines and pharmaceutical preparations for use as immunosuppressive agents, for example for organ transplant or other medical (and clinical) uses of immunosuppressive agents or preparations; Medicines and pharmaceutical preparations for use as immunosuppressive agents in organ transplants or other medical and clinical uses of immunosuppressive agents and preparations; Medicines and pharmaceutical preparations for use as immunosuppressive agents, for example organ transplant or other uses of immunosuppressive agents; Medicines and pharmaceutical preparations for use within the area of neurological intensive care; Medicines for animals; Medicines for human purposes; medicines for veterinary purposes; mixed biological preparations for medical purposes; mixed biological preparations for veterinary purposes; nutritional supplements; Nutritional supplements for livestock feed; ointments for medical purposes; Pharmaceutical and veterinary preparations; Pharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for the treatment and prevention of acute and chronic neurological illnesses and conditions; Pharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for acute and chronic neurological illnesses and conditions and for preventative treatment; Pharmaceutical drugs; pharmaceutical preparations; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides; Pharmaceutical preparations and substances; Pharmaceutical preparations and substances for the prevention of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations for activating cellular function; Pharmaceutical preparations for animals; Pharmaceutical preparations for human use; Pharmaceutical preparations for medical purposes and veterinary purposes; Pharmaceutical preparations for medical use consisting of a cyclosporin as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions; Pharmaceutical preparations for medical use consisting of a cyclosporin or another cyclophilin inhibitor as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions; pharmaceutical preparations for skin care; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the prevention of diseases of the nervous system; Pharmaceutical preparations for the prevention of diseases of the metabolic system; Pharmaceutical preparations for the prevention of disorders of the metabolic system; Pharmaceutical preparations for the prevention of disorders of the nervous system; Pharmaceutical preparations for the prevention of tumours; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; Pharmaceutical preparations for the treatment of diseases caused by bacteria; Pharmaceutical preparations for the treatment of diseases of the metabolic system; Pharmaceutical preparations for the treatment of disorders of the metabolic system; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of kidney disorders; Pharmaceutical preparations for the treatment of Parkinson's disease; Pharmaceutical preparations for the treatment of tumours; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating heatstroke; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations for treating metabolic disorders; Pharmaceutical preparations for treating peripheral nervous system disorders; Pharmaceutical preparations for use as immunosuppressive agents; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in organ transplantation; Pharmaceutical preparations for use in tissue transplantation; Pharmaceutical preparations for use within the area of neurological intensive care; Pharmaceutical preparations for veterinary use; pharmaceuticals; Pharmaceuticals, medical and veterinary preparations; phosphates for pharmaceutical purposes; phosphates for veterinary purposes; Plasters, materials for dressings; potassium salts for medical purposes; potassium salts for veterinary purposes; Preparations for destroying vermin; quinine for medical purposes; quinine for veterinary purposes; salts for medical purposes; salts for veterinary purposes; Sanitary preparations for medical purposes; sanitary preparations for veterinary purposes; slimming pills; sodium salts for medical purposes; sodium salts for veterinary purposes; sulfonamides [medicines]; tinctures for medical purposes; tinctures for veterinary purposes; tonics [medicines]; tonics for medical use; tonics for veterinary use; vaccines; vaccines for human use; veterinary preparations; Veterinary preparations and substances; Veterinary vaccines; drugs and pharmaceutical preparations for acute and chronic neurological diseases and conditions (including preventive treatment); Esters for veterinary use; esters for veterinary purposes. Apparatus and instruments for measuring, testing and analyzing biological samples, blood or other bodily fluids, not for medical purposes; chromatography apparatus for laboratory use; diagnostic apparatus, not for medical purposes; DNA chips; laboratory apparatus and instruments; quantity indicators respirometer; scientific research and laboratory apparatus, educational apparatus and simulators; electrodes for laboratory research. Apparatus for analyzing substances [for medical use]; apparatus for blood tests [for medical use]; apparatus for use in medical analysis; blood testing apparatus; blood testing equipment; electrodes for medical use; medical analytical apparatus for medical purposes; medical apparatus and instruments; medical diagnostic apparatus for medical purposes; medical diagnostic instruments; probes for medical purposes; probes for veterinary purposes; medical electrodes; electrodes for use in connection with medical apparatus; electrodes for cardiology; electrodes for veterinary use, namely medical electrodes. Analysis of human tissues for medical research; bacteriological analysism, consultation; biochemical research; biological analysis; biological laboratory services; biological research and analysis; biological research, clinical research and medical research; Biological sample analysis for scientific and medical research purposes; Biological samples, blood or other bodily fluids analysis services for scientific and medical research purposes; biotechnology research; blood analysis services; Blood analysis services for scientific and medical re-search purposes; chemical analysis and research; Chemical research and analysis ser-vices; Chemistry consultancy services; clinical research; clinical research and trials; Clinical trials; conducting clinical trials; Conducting clinical trials for others; Conducting clinical trials for pharmaceutical products; conducting early evaluations in the field of new pharmaceuticals; Consultancy in the field of cosmetics, namely, consultancy in connection with the quality inspection, research and development of cosmetic products and medicated cosmetic products; Consultancy in the field of sanitary research for medical purpose; consultancy in pharmaceutical, pharmacogenetics, medical chemistry, veterinary, for research purposes; Consultancy services in the field of biology; Consultancy services in the field of biotechnology; Consulting on pharmacogenetics; cosmetic research; Cosmetic research and analysis services; Cosmetic research services and laboratory analysis services in the field of cosmetics; Design and development of computer hardware and software; Design and development of diagnostic apparatus and instruments; Design and development of medical diagnostic apparatus and instruments; development, testing and consultancy services in the fields of biotechnology, pharmaceutical, medical, sanitary, veterinary, chemistry, biology and pharmacogenetics; DNA analysis for scientific and medical research purposes; Drug and pharmaceutical discovery, testing and development services; drug discovery services; Industrial analysis and research services; laboratory research services relating to pharmaceuticals; Medical and veterinary research and development and consultancy related there-to; medical laboratory services; medical research; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services; providing information in connection with all the aforementioned services; Providing medical and veterinary testing services in the field of research relating to medicines, drug discovery, drug development and drug screening and consultancy related thereto; research and development in the field of biotechnology; research and development in the field of microorganisms and cells; research and development in the pharmaceutical and biotechnology fields; research and development services; research and testing; research of pharmaceuticals; research relating to biotechnology; research relating to pharmaceuticals; Research, development, and testing services, and consultancy related thereto, in the fields of biotechnology, pharmaceuticals, chemistry, biology and pharmacogenetics; Research, development, and testing services, and consultancy related thereto, in the medical, sanitary, veterinary fields; Research, development, and testing services, and consultancy related thereto, in the fields of biotechnology, pharmaceuticals, sanitary products, chemistry, biology and pharmacogenetics; Research, development, testing and consultancy services in the fields of biotechnology, pharmaceutical, medical, sanitary, veterinary, chemistry, biology and pharmacogenetics; Research, development, testing, scientific consultancy services in the fields of biotechnology, pharmaceutical, medical, sanitary, veterinary, chemistry, biology and pharmacogenetics; research, research in the field of environmental protection; Re-search, test and development of sanitary, pharmaceutical, medical, medicinal chemical, veterinary preparations; research, test and development of biotechnical, biological preparations; research, testing and development in the field of diagnostic preparations; Research, testing and development in the field of diagnostic preparations; Research, testing and development of diagnostic preparations for medical purpose; scientific analysis; Scientific and technological services and research and design relating thereto; scientific laboratory ser-vices; scientific research; scientific research relating to cosmetics; testing of pharmaceuticals; toxicity analysis; toxicity testing for research purposes; Veterinary laboratory services. Agriculture, horticulture and forestry service; Analysis of human serum for medical treatment; analysis of human tissues for medical treatment; Consultancy in the dental medicare field; consultancy in the field of cosmetics; Consultancy in the field of cosmetics, namely consultancy in connection with the selection of cosmetic products and medicated cosmetic products; Consultancy in the medical field (other than dentistry); drug screening for medical purposes; health care; health care services; Hygienic and beauty care for human beings or animals; medical and surgical diagnostic services; Medical and surgical diagnostic services; Medical consultancy in the field of pharmacogenetics; Medical consultancy services; medical diagnostic services; Medical services; Medical testing for diagnostic or treatment purposes; Pharmaceutical consultancy services; providing information in connection with all the aforementioned services; rental of ultrasonic diagnostic apparatus; therapy services; Veterinary consultancy services; Veterinary services.

22.

NEUROVIVE

      
Serial Number 79250595
Status Registered
Filing Date 2018-11-09
Registration Date 2020-07-28
Owner Abliva AB (Sweden)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

[ Acetates for pharmaceutical purposes; acids for pharmaceutical purposes; adjuvants for medical purposes; aldehydes for pharmaceutical purposes; alginates for pharmaceutical purposes; amino acids for medical purposes; amino acids for veterinary purposes; antibiotics; antidiabetic pharmaceuticals; food supplements, namely, antioxidant pills; food supplements, namely, antioxidants; antitumor drugs in the nature of tumor suppressing agents; appetite suppressant pills; appetite suppressants; appetite suppressants for medical purposes; appetite suppressants for veterinary purposes; bacterial preparations for medical use; bacterial preparations for veterinary use; bacteriological culture mediums; bacteriological preparations for medical purposes; bacteriological preparations for medical use; bacteriological preparations for veterinary purposes; bacteriological preparations for veterinary use; biological preparations for medical purposes for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; biological preparations for the treatment of cancer; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological tissues for implantation being implants comprising living tissue; bouillons for bacteriological cultures; cachets being capsules sold empty for pharmaceutical preparations; capsules sold empty for pharmaceutical preparations; castor oil for medical purposes; cellulose ethers for pharmaceutical purposes; chemical preparations for medical purposes, namely, for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; chemical preparations for pharmaceutical purposes, namely, for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; chemicopharmaceutical preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; cytostatic drugs for medical purposes; decoctions for pharmaceutical purposes, namely, for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; dental wax; diagnostic biomarker reagents for medical purposes; diagnostic biomarker reagents for veterinary purposes; diagnostic preparations for medical and veterinary use; diagnostic preparations for medical use; diagnostic preparations for veterinary use; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic radiopharmaceutical preparations; dietary supplements for animals; dietary supplements for humans; dietetic food and substances adapted for medical or veterinary use, namely, food for human and animal babies; dietetic food and substances adapted for medical or veterinary use; dietetic substances adapted for medical use, namely, food for babies; digestive enzymes being dietary supplements; disinfectants; drugs for medical purposes in the nature of medical preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical preparations, namely, elixirs for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; enzyme dietary supplements; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; enzymes for medical purposes; enzymes for veterinary purposes; esters for pharmaceutical use; ethers for pharmaceutical purposes; ferments for pharmaceutical purposes; ferments for pharmaceutical use; ferments for veterinary purposes; ferments for veterinary use; food esters for pharmaceutical purposes; formic aldehyde for pharmaceutical purposes; formic aldehyde for veterinary purposes; ] fungicides, herbicides; [ in vitro diagnostic preparations for medical use; skin lotions for medical purposes; skin lotions for pharmaceutical purposes; material for stopping teeth; material for stopping teeth, dental wax; media for bacteriological cultures; medical and veterinary preparations and products for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; medical preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; medical preparations for slimming purposes; medical vaccines; medicated animal feed; medicinal drinks; medicinal infusions for treating metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; medicinal oils; medicines and pharmaceutical preparations for neurosurgical conditions, brain damage, and neurological operations; medicines and pharmaceutical preparations for neurosurgical conditions, brain damage and brain operations; medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, brain damage, brain operations, and other physical and neurological ailments of the brain; medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, namely, for brain damage and for use in brain operations and other physical and neurological ailments of the brain; medicines and pharmaceutical preparations for use as immunosuppressive agents; medicines and pharmaceutical preparations for use as immunosuppressive agents in organ transplants or other medical and clinical uses of immunosuppressive agents; medicines and pharmaceutical preparations for use as immunosuppressive agents for organ transplants; medicines and pharmaceutical preparations for neurological conditions within the area of neurological intensive care; medicines for human purposes in the nature of medicinal preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; mixed biological preparations for medical purposes, namely, for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; nutritional supplements; nutritional supplements for livestock feed; medicated ointments for medical purposes, namely, for treating dermatological conditions; pharmaceutical and veterinary preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for the treatment and prevention of acute and chronic neurological illnesses and conditions; pharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for acute and chronic neurological illnesses and conditions and for preventative treatment; pharmaceutical drugs in the nature of pharmaceutical preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and other ] preparations for destroying vermin; fungicides and herbicides [ ; pharmaceutical preparations and substances for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for human use for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical preparations for medical purposes and veterinary purposes, namely, for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical preparations for medical use consisting of a cyclosporin as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions; pharmaceutical preparations for medical use consisting of a cyclosporin or another cyclophilin inhibitor as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions; pharmaceutical preparations for skin care; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the prevention of diseases of the nervous system; pharmaceutical preparations for the prevention of diseases of the metabolic system; pharmaceutical preparations for the prevention of disorders of the metabolic system; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for the prevention of tumors; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for the treatment of diseases caused by bacteria in the nature of antibacterial pharmaceuticals; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of disorders of the metabolic system; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of Parkinson's disease; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for the treatment of viral diseases in the nature of antivirals; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating heatstroke; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for use as immunosuppressive agents; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in organ transplantation; pharmaceutical preparations for use in tissue transplantation; pharmaceutical preparations for neurological conditions within the area of neurological intensive care; pharmaceutical preparations for the prevention of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical preparations for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; medical and veterinary preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; phosphates for pharmaceutical purposes; phosphates for veterinary purposes; medical plasters; medical dressings; potassium salts for medical purposes; potassium salts for veterinary purposes; preparations for destroying vermin; quinine for medical purposes; quinine for veterinary purposes; mineral salts for medical purposes; sanitary preparations for medical purposes; sanitary preparations for veterinary purposes; slimming pills being medical preparations for slimming purposes; sodium salts for medical purposes; sodium salts for veterinary purposes; sulfonamide preparations; tinctures being medicinal drinks for medical purposes; tinctures being medicinal drinks for veterinary purposes; tonics being medicinal drinks; tonics being medicinal drinks for medical use; tonics being medicinal drinks for veterinary use; vaccines; vaccines for human use; veterinary vaccines; drugs and pharmaceutical preparations for acute and chronic neurological diseases and conditions including preventive treatment; the aforementioned rare diseases consisting of Alpers Disease, ALS (Amyotrophic Lateral Sclerosis), Autism, Barth syndrome, Complex I Deficiency (NADH dehydrogenase deficiency), Complex II Deficiency (NADH-CoQ reductase deficiency), Complex III Deficiency (Ubiquinone-cytochrome c oxidoreductase deficiency), Complex IV Deficiency/COX Deficiency, Complex V Deficiency (ATP synthase deficiency), CPEO (Chronic Progressive External Ophthalmoplegia Syndrome), Friedreich's ataxia (FRDA or FA), KSS (Kearns-Sayre Syndrome), Lactic Acidosis, Leigh Disease or Syndrome (Subacute Necrotizing Encephalomyelopathy), LHON (Leber's hereditary optic neuropathy), MELAS (Mitochondrial Encephalomyopathy Lactic Acidosis and Strokelike Episodes), MERRF (Myoclonic Epilepsy and Ragged-Red Fiber Disease), MIDD (Maternally Inherited Diabetes and Deafness), Mitochondrial Myopathy, MNGIE (Myoneurogastointestinal Disorder and Encephalopathy, NARP) (Neuropathy, Ataxia, and Retinitis Pigmentosa), Neurodegenerative disorders associated with Parkinson's, Alzheimer's or Huntington's disease, Pearson Syndrome, Pyruvate Carboxylase Deficiency, Pyruvate Dehydrogenase Deficiency, POLG Mutations ] Chromatography apparatus for laboratory use; DNA chips; electrodes for laboratory research [ Blood testing apparatus; electrodes for medical use; probes for medical purposes; probes for veterinary purposes; electrodes for veterinary use, namely, medical electrodes ] [ Analysis of human tissues for medical research; bacteriological analysis and consultation relating thereto; biochemical research; biological analysis; scientific biological laboratory services; biological research and analysis; biological research, medical research and clinical research in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; biological sample analysis for scientific and medical research purposes; biological samples, blood or other bodily fluids analysis services for scientific and medical research purposes; biotechnology research; blood analysis services; blood analysis services for scientific and medical research purposes; chemical analysis and research; chemical research and analysis services; chemistry consultancy services; clinical research in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; clinical research and trials for others in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; scientific research, namely, conducting clinical trials for others; conducting clinical trials being scientific research for others; conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; conducting early evaluations in the field of new pharmaceuticals; ] consultancy in the field of cosmetics, namely, consultancy in connection with the quality inspection, research and development of cosmetic products and medicated cosmetic products; [ consultancy in the field of sanitary research for medical purpose; consultancy in pharmaceutical, pharmacogenetics, medical chemistry, and veterinary research; consultancy services in the field of biological research; consultancy services in the field of biotechnology; consulting on pharmacogenetics in the nature of pharmaceutical consultation; ] cosmetics research; cosmetics research and analysis services; cosmetics research services and laboratory analysis services in the field of cosmetics; design and development of computer hardware and software; [ design and development of diagnostic apparatus and instruments for medical use; design and development of medical diagnostic apparatus and instruments; development, testing and consultancy services in the fields of biotechnology research, pharmaceutical research, medical research, veterinary medicine research, chemistry research, biology research, and pharmacogenetics research; DNA analysis for scientific and medical research purposes; drug and pharmaceutical discovery, testing and development services; drug discovery services; industrial analysis and research services in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; laboratory research services relating to pharmaceuticals; medical and veterinary product research and development and consultancy related thereto; medical laboratory services; medical research; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services; providing information in connection with all the aforementioned services; providing medical and veterinary testing services in the field of research relating to medicines, drug discovery, drug development and drug screening, and consultancy related thereto; research and development in the field of biotechnology; biochemical research and development of microorganisms and cells; research and development in the pharmaceutical and biotechnology fields; scientific research and development services; research and testing in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; research of pharmaceuticals; research relating to biotechnology; research relating to pharmaceuticals; research, development, and testing services, and consultancy related thereto, in the fields of biotechnology products, pharmaceutical products, sanitary products, medical products, veterinary products, chemistry products, biology products, and pharmacogenetics products; research, development, and testing services, and consultancy related thereto, in the fields of biotechnology, pharmaceuticals, sanitary products, chemistry, biology and pharmacogenetics; research, development, testing and consultancy services in the fields of biotechnology products, pharmaceutical products, medical products, sanitary products, veterinary products, chemistry products, biology products, and pharmacogenetics products; research, development, testing, scientific consultancy services in the fields of biotechnology products, pharmaceutical products, medical products, sanitary products, veterinary products, chemistry products, biology products, and pharmacogenetics products; research in the field of environmental protection; research, testing and development of sanitary, pharmaceutical, medical, medicinal chemical, veterinary preparations; research, testing and development of biotechnical, biological preparations; research, testing and development in the field of diagnostic preparations; research, testing and development of diagnostic preparations for medical purpose; scientific analysis in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; scientific and technological services, namely, scientific research, analysis and testing in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction, and research and design relating thereto; scientific laboratory services; scientific research; ] scientific research relating to cosmetics [ ; testing of pharmaceuticals; blood toxicity analysis; toxicity testing in the nature of drug screening for research purposes; veterinary laboratory services; the aforementioned rare diseases consisting of Alpers Disease, ALS (Amyotrophic Lateral Sclerosis), Autism, Barth syndrome, Complex I Deficiency (NADH dehydrogenase deficiency), Complex II Deficiency (NADH-CoQ reductase deficiency), Complex III Deficiency (Ubiquinone-cytochrome c oxidoreductase deficiency), Complex IV Deficiency/COX Deficiency, Complex V Deficiency (ATP synthase deficiency), CPEO (Chronic Progressive External Ophthalmoplegia Syndrome), Friedreich's ataxia (FRDA or FA), KSS (Kearns-Sayre Syndrome), Lactic Acidosis, Leigh Disease or Syndrome (Subacute Necrotizing Encephalomyelopathy), LHON (Leber's hereditary optic neuropathy), MELAS (Mitochondrial Encephalomyopathy Lactic Acidosis and Strokelike Episodes), MERRF (Myoclonic Epilepsy and Ragged-Red Fiber Disease), MIDD (Maternally Inherited Diabetes and Deafness), Mitochondrial Myopathy, MNGIE (Myoneurogastointestinal Disorder and Encephalopathy, NARP) (Neuropathy, Ataxia, and Retinitis Pigmentosa), Neurodegenerative disorders associated with Parkinson's, Alzheimer's or Huntington's disease, Pearson Syndrome, Pyruvate Carboxylase Deficiency, Pyruvate Dehydrogenase Deficiency, POLG Mutations ] [ Analysis of human serum for medical treatment; analysis of human tissues for medical treatment; ] consultancy in the field of cosmetics, namely, consultancy in connection with the selection of cosmetic products and medicated cosmetic products; [ consultancy in the medical field, other than dentistry; drug screening for medical purposes; health care; health care services; ] hygienic and beauty care for human beings or animals; [ medical and surgical diagnostic testing services; medical consultancy in the field of pharmacogenetics; medical consultancy services; medical diagnostic services in the nature of performing diagnosis of diseases; medical services; medical testing for diagnostic or treatment purposes; pharmaceutical consultancy services; ] providing information in connection with all the aforementioned services; rental of ultrasonic diagnostic apparatus [ ; veterinary consultancy services; veterinary services ]

23.

NP NEUROVIVE PHARMACEUTICAL

      
Application Number 017982037
Status Registered
Filing Date 2018-11-09
Registration Date 2021-08-12
Owner Abliva AB (Sweden)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

esters for foodstuffs, not for pharmaceutical purposes. Fungicides, herbicides; other preparations for destroying vermin, fungicides, herbicides. Apparatus and instruments for measuring, testing and analyzing biological samples, blood or other bodily fluids, not for medical purposes; chromatography apparatus for laboratory use; diagnostic apparatus, not for medical purposes; DNA chips; laboratory apparatus and instruments; quantity indicators respirometer; scientific research and laboratory apparatus, educational apparatus and simulators; electrodes for laboratory research. Consultancy in the field of cosmetics, namely, consultancy in connection with the quality inspection, research and development of cosmetic products and medicated cosmetic products; Cosmetic research and analysis services; Cosmetic research services and laboratory analysis services in the field of cosmetics; Design and development of computer hardware and software; scientific research relating to cosmetics. Agriculture, horticulture and forestry service; consultancy in the field of cosmetics; Consultancy in the field of cosmetics, namely consultancy in connection with the selection of cosmetic products and medicated cosmetic products; Hygienic and beauty care for human beings or animals; providing information in connection with all the aforementioned services; rental of ultrasonic diagnostic apparatus; therapy services.

24.

NP NEUROVIVE PHARMACEUTICAL

      
Serial Number 79250939
Status Registered
Filing Date 2018-11-09
Registration Date 2020-07-28
Owner Abliva AB (Sweden)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

[ Acetates for pharmaceutical purposes; acids for pharmaceutical purposes; adjuvants for medical purposes; aldehydes for pharmaceutical purposes; alginates for pharmaceutical purposes; amino acids for medical purposes; amino acids for veterinary purposes; antibiotics; antidiabetic pharmaceuticals; food supplements, namely, antioxidant pills; food supplements, namely, antioxidants; antitumor drugs in the nature of tumor suppressing agents; appetite suppressant pills; appetite suppressants; appetite suppressants for medical purposes; appetite suppressants for veterinary purposes; bacterial preparations for medical use; bacterial preparations for veterinary use; bacteriological culture mediums; bacteriological preparations for medical purposes; bacteriological preparations for medical use; bacteriological preparations for veterinary purposes; bacteriological preparations for veterinary use; biological preparations for medical purposes for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; biological preparations for the treatment of cancer; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological tissues for implantation being implants comprising living tissue; bouillons for bacteriological cultures; cachets being capsules sold empty for pharmaceutical preparations; capsules sold empty for pharmaceutical preparations; castor oil for medical purposes; cellulose ethers for pharmaceutical purposes; chemical preparations for medical purposes, namely, for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; chemical preparations for pharmaceutical purposes, namely, for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; chemicopharmaceutical preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; cytostatic drugs for medical purposes; decoctions for pharmaceutical purposes, namely, for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; dental wax; diagnostic biomarker reagents for medical purposes; diagnostic biomarker reagents for veterinary purposes; diagnostic preparations for medical and veterinary use; diagnostic preparations for medical use; diagnostic preparations for veterinary use; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic radiopharmaceutical preparations; dietary supplements for animals; dietary supplements for humans; dietetic food and substances adapted for medical or veterinary use, namely, food for human and animal babies; dietetic food and substances adapted for medical or veterinary use; dietetic substances adapted for medical use, namely, food for babies; digestive enzymes being dietary supplements; disinfectants; drugs for medical purposes in the nature of medical preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical preparations, namely, elixirs for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; enzyme dietary supplements; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; enzymes for medical purposes; enzymes for veterinary purposes; esters for pharmaceutical use; ethers for pharmaceutical purposes; ferments for pharmaceutical purposes; ferments for pharmaceutical use; ferments for veterinary purposes; ferments for veterinary use; food esters for pharmaceutical purposes; formic aldehyde for pharmaceutical purposes; formic aldehyde for veterinary purposes; ] fungicides, herbicides; [ in vitro diagnostic preparations for medical use; skin lotions for medical purposes; skin lotions for pharmaceutical purposes; material for stopping teeth; material for stopping teeth, dental wax; media for bacteriological cultures; medical and veterinary preparations and products for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; medical preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; medical preparations for slimming purposes; medical vaccines; medicated animal feed; medicinal drinks; medicinal infusions for treating metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; medicinal oils; medicines and pharmaceutical preparations for neurosurgical conditions, brain damage, and neurological operations; medicines and pharmaceutical preparations for neurosurgical conditions, brain damage and brain operations; medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, brain damage, brain operations, and other physical and neurological ailments of the brain; medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, namely, for brain damage and for use in brain operations and other physical and neurological ailments of the brain; medicines and pharmaceutical preparations for use as immunosuppressive agents; medicines and pharmaceutical preparations for use as immunosuppressive agents in organ transplants or other medical and clinical uses of immunosuppressive agents; medicines and pharmaceutical preparations for use as immunosuppressive agents for organ transplants; medicines and pharmaceutical preparations for neurological conditions within the area of neurological intensive care; medicines for human purposes in the nature of medicinal preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; mixed biological preparations for medical purposes, namely, for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; nutritional supplements; nutritional supplements for livestock feed; medicated ointments for medical purposes, namely, for treating dermatological conditions; pharmaceutical and veterinary preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for the treatment and prevention of acute and chronic neurological illnesses and conditions; pharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for acute and chronic neurological illnesses and conditions and for preventative treatment; pharmaceutical drugs in the nature of pharmaceutical preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and ] other preparations for destroying vermin; fungicides and herbicides [ ; pharmaceutical preparations and substances for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for human use for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical preparations for medical purposes and veterinary purposes, namely, for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical preparations for medical use consisting of a cyclosporin as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions; pharmaceutical preparations for medical use consisting of a cyclosporin or another cyclophilin inhibitor as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions; pharmaceutical preparations for skin care; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the prevention of diseases of the nervous system; pharmaceutical preparations for the prevention of diseases of the metabolic system; pharmaceutical preparations for the prevention of disorders of the metabolic system; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for the prevention of tumors; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for the treatment of diseases caused by bacteria in the nature of antibacterial pharmaceuticals; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of disorders of the metabolic system; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of Parkinson's disease; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for the treatment of viral diseases in the nature of antivirals; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating heatstroke; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for use as immunosuppressive agents; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in organ transplantation; pharmaceutical preparations for use in tissue transplantation; pharmaceutical preparations for neurological conditions within the area of neurological intensive care; pharmaceutical preparations for the prevention of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical preparations for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; medical and veterinary preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; phosphates for pharmaceutical purposes; phosphates for veterinary purposes; medical plasters; medical dressings; potassium salts for medical purposes; potassium salts for veterinary purposes; preparations for destroying vermin; quinine for medical purposes; quinine for veterinary purposes; mineral salts for medical purposes; sanitary preparations for medical purposes; sanitary preparations for veterinary purposes; slimming pills being medical preparations for slimming purposes; sodium salts for medical purposes; sodium salts for veterinary purposes; sulfonamide preparations; tinctures being medicinal drinks for medical purposes; tinctures being medicinal drinks for veterinary purposes; tonics being medicinal drinks; tonics being medicinal drinks for medical use; tonics being medicinal drinks for veterinary use; vaccines; vaccines for human use; veterinary vaccines; drugs and pharmaceutical preparations for acute and chronic neurological diseases and conditions including preventive treatment; the aforementioned rare diseases consisting of Alpers Disease, ALS (Amyotrophic Lateral Sclerosis), Autism, Barth syndrome, Complex I Deficiency (NADH dehydrogenase deficiency), Complex II Deficiency (NADH-CoQ reductase deficiency), Complex III Deficiency (Ubiquinone-cytochrome c oxidoreductase deficiency), Complex IV Deficiency/COX Deficiency, Complex V Deficiency (ATP synthase deficiency), CPEO (Chronic Progressive External Ophthalmoplegia Syndrome), Friedreich's ataxia (FRDA or FA), KSS (Kearns-Sayre Syndrome), Lactic Acidosis, Leigh Disease or Syndrome (Subacute Necrotizing Encephalomyelopathy), LHON (Leber's hereditary optic neuropathy), MELAS (Mitochondrial Encephalomyopathy Lactic Acidosis and Strokelike Episodes), MERRF (Myoclonic Epilepsy and Ragged-Red Fiber Disease), MIDD (Maternally Inherited Diabetes and Deafness), Mitochondrial Myopathy, MNGIE (Myoneurogastointestinal Disorder ) and Encephalopathy, NARP (Neuropathy, Ataxia, and Retinitis Pigmentosa), Neurodegenerative disorders associated with Parkinson's, Alzheimer's or Huntington's disease, Pearson Syndrome, Pyruvate Carboxylase Deficiency, Pyruvate Dehydrogenase Deficiency, POLG Mutations ] Chromatography apparatus for laboratory use; DNA chips; electrodes for laboratory research [ Blood testing apparatus; electrodes for medical use; probes for medical purposes; probes for veterinary purposes; electrodes for veterinary use, namely, medical electrodes ] [ Analysis of human tissues for medical research; bacteriological analysis and consultation relating thereto; biochemical research; biological analysis; scientific biological laboratory services; biological research and analysis; biological research, medical research and clinical research in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; biological sample analysis for scientific and medical research purposes; biological samples, blood or other bodily fluids analysis services for scientific and medical research purposes; biotechnology research; blood analysis services; blood analysis services for scientific and medical research purposes; chemical analysis and research; chemical research and analysis services; chemistry consultancy services; clinical research in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; clinical research and trials for others in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; scientific research, namely, conducting clinical trials for others; conducting clinical trials being scientific research for others; conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; conducting early evaluations in the field of new pharmaceuticals; ] consultancy in the field of cosmetics, namely, consultancy in connection with the quality inspection, research and development of cosmetic products and medicated cosmetic products [ ; consultancy in the field of sanitary research for medical purpose; consultancy in pharmaceutical, pharmacogenetics, medical chemistry, and veterinary research; consultancy services in the field of biological research; consultancy services in the field of biotechnology; consulting on pharmacogenetics in the nature of pharmaceutical consultation; cosmetics research; cosmetics research and analysis services; cosmetics research services and laboratory analysis services in the field of cosmetics; design and development of computer hardware and software; design and development of diagnostic apparatus and instruments for medical use; design and development of medical diagnostic apparatus and instruments; development, testing and consultancy services in the fields of biotechnology research, pharmaceutical research, medical research, veterinary medicine research, chemistry research, biology research, and pharmacogenetics research; DNA analysis for scientific and medical research purposes; drug and pharmaceutical discovery, testing and development services; drug discovery services; industrial analysis and research services in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; laboratory research services relating to pharmaceuticals; medical and veterinary product research and development and consultancy related thereto; medical laboratory services; medical research; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services; providing information in connection with all the aforementioned services; providing medical and veterinary testing services in the field of research relating to medicines, drug discovery, drug development and drug screening, and consultancy related thereto; research and development in the field of biotechnology; biochemical research and development of microorganisms and cells; research and development in the pharmaceutical and biotechnology fields; scientific research and development services; research and testing in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; research of pharmaceuticals; research relating to biotechnology; research relating to pharmaceuticals; research, development, and testing services, and consultancy related thereto, in the fields of biotechnology products, pharmaceutical products, sanitary products, medical products, veterinary products, chemistry products, biology products, and pharmacogenetics products; research, development, and testing services, and consultancy related thereto, in the fields of biotechnology, pharmaceuticals, sanitary products, chemistry, biology and pharmacogenetics; research, development, testing and consultancy services in the fields of biotechnology products, pharmaceutical products, medical products, sanitary products, veterinary products, chemistry products, biology products, and pharmacogenetics products; research, development, testing, scientific consultancy services in the fields of biotechnology products, pharmaceutical products, medical products, sanitary products, veterinary products, chemistry products, biology products, and pharmacogenetics products; research in the field of environmental protection; research, testing and development of sanitary, pharmaceutical, medical, medicinal chemical, veterinary preparations; research, testing and development of biotechnical, biological preparations; research, testing and development in the field of diagnostic preparations; research, testing and development of diagnostic preparations for medical purpose; scientific analysis in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; scientific and technological services, namely, scientific research, analysis and testing in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction, and research and design relating thereto; scientific laboratory services; scientific research; scientific research relating to cosmetics; testing of pharmaceuticals; blood toxicity analysis; toxicity testing in the nature of drug screening for research purposes; veterinary laboratory services; the aforementioned rare diseases consisting of Alpers Disease, ALS (Amyotrophic Lateral Sclerosis), Autism, Barth syndrome, Complex I Deficiency (NADH dehydrogenase deficiency), Complex II Deficiency (NADH-CoQ reductase deficiency), Complex III Deficiency (Ubiquinone-cytochrome c oxidoreductase deficiency), Complex IV Deficiency/COX Deficiency, Complex V Deficiency (ATP synthase deficiency), CPEO (Chronic Progressive External Ophthalmoplegia Syndrome), Friedreich's ataxia (FRDA or FA), KSS (Kearns-Sayre Syndrome), Lactic Acidosis, Leigh Disease or Syndrome (Subacute Necrotizing Encephalomyelopathy), LHON (Leber's hereditary optic neuropathy), MELAS (Mitochondrial Encephalomyopathy Lactic Acidosis and Strokelike Episodes), MERRF (Myoclonic Epilepsy and Ragged-Red Fiber Disease), MIDD (Maternally Inherited Diabetes and Deafness), Mitochondrial Myopathy, MNGIE (Myoneurogastointestinal Disorder ) and Encephalopathy, NARP (Neuropathy, Ataxia, and Retinitis Pigmentosa), Neurodegenerative disorders associated with Parkinson's, Alzheimer's or Huntington's disease, Pearson Syndrome, Pyruvate Carboxylase Deficiency, Pyruvate Dehydrogenase Deficiency, POLG Mutations ] [ -Analysis of human serum for medical treatment; analysis of human tissues for medical treatment; ] consultancy in the field of cosmetics, namely, consultancy in connection with the selection of cosmetic products and medicated cosmetic products; [ consultancy in the medical field, other than dentistry; drug screening for medical purposes; health care; health care services; ] hygienic and beauty care for human beings or animals; [ medical and surgical diagnostic testing services; medical consultancy in the field of pharmacogenetics; medical consultancy services; medical diagnostic services in the nature of performing diagnosis of diseases; medical services; medical testing for diagnostic or treatment purposes; pharmaceutical consultancy services; ] providing information in connection with all the aforementioned services; rental of ultrasonic diagnostic apparatus [ ; veterinary consultancy services; veterinary services ]

25.

NP

      
Serial Number 79258394
Status Registered
Filing Date 2018-11-09
Registration Date 2020-02-18
Owner Abliva AB (Sweden)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Acetates for pharmaceutical purposes; acids for pharmaceutical purposes; adjuvants for medical purposes; aldehydes for pharmaceutical purposes; alginates for pharmaceutical purposes; amino acids for medical purposes; amino acids for veterinary purposes; antibiotics; antidiabetic pharmaceuticals; food supplements, namely, antioxidant pills; food supplements, namely, antioxidants; antitumor drugs in the nature of tumor suppressing agents; appetite suppressant pills; appetite suppressants; appetite suppressants for medical purposes; appetite suppressants for veterinary purposes; bacterial preparations for medical use; bacterial preparations for veterinary use; bacteriological culture mediums; bacteriological preparations for medical purposes; bacteriological preparations for medical use; bacteriological preparations for veterinary purposes; bacteriological preparations for veterinary use; biological preparations for medical purposes for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; biological preparations for the treatment of cancer; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological tissues for implantation being implants comprising living tissue; bouillons for bacteriological cultures; cachets being capsules sold empty for pharmaceutical preparations; capsules sold empty for pharmaceutical preparations; castor oil for medical purposes; cellulose ethers for pharmaceutical purposes; chemical preparations for medical purposes, namely, for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; chemical preparations for pharmaceutical purposes, namely, for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; chemicopharmaceutical preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; cytostatic drugs for medical purposes; decoctions for pharmaceutical purposes, namely, for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; dental wax; diagnostic biomarker reagents for medical purposes; diagnostic biomarker reagents for veterinary purposes; diagnostic preparations for medical and veterinary use; diagnostic preparations for medical use; diagnostic preparations for veterinary use; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic radiopharmaceutical preparations; dietary supplements for animals; dietary supplements for humans; dietetic food and substances adapted for medical or veterinary use, namely, food for human and animal babies; dietetic food and substances adapted for medical or veterinary use; dietetic substances adapted for medical use, namely, food for babies; digestive enzymes being dietary supplements; disinfectants; drugs for medical purposes in the nature of medical preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; pharmaceutical preparations, namely, elixirs for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; enzyme dietary supplements; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; enzymes for medical purposes; enzymes for veterinary purposes; esters for pharmaceutical use; ethers for pharmaceutical purposes; ferments for pharmaceutical purposes; ferments for pharmaceutical use; ferments for veterinary purposes; ferments for veterinary use; food esters for pharmaceutical purposes; formic aldehyde for pharmaceutical purposes; formic aldehyde for veterinary purposes; fungicides, herbicides; in vitro diagnostic preparations for medical use; skin lotions for medical purposes; skin lotions for pharmaceutical purposes; material for stopping teeth; material for stopping teeth, dental wax; media for bacteriological cultures; medical and veterinary preparations and products for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; medical preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; medical preparations for slimming purposes; medical vaccines; medicated animal feed; medicinal drinks; medicinal infusions for treating metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; medicinal oils; medicines and pharmaceutical preparations for neurosurgical conditions, brain damage, and neurological operations; medicines and pharmaceutical preparations for neurosurgical conditions, brain damage and brain operations; medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, brain damage, brain operations, and other physical and neurological ailments of the brain; medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, namely, for brain damage and for use in brain operations and other physical and neurological ailments of the brain; medicines and pharmaceutical preparations for use as immunosuppressive agents; medicines and pharmaceutical preparations for use as immunosuppressive agents in organ transplants or other medical and clinical uses of immunosuppressive agents; medicines and pharmaceutical preparations for use as immunosuppressive agents for organ transplants; medicines and pharmaceutical preparations for neurological conditions within the area of neurological intensive care; medicines for human purposes in the nature of medicinal preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; mixed biological preparations for medical purposes, namely, for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; nutritional supplements; nutritional supplements for livestock feed; medicated ointments for medical purposes, namely, for treating dermatological conditions; pharmaceutical and veterinary preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; pharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for the treatment and prevention of acute and chronic neurological illnesses and conditions; pharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for acute and chronic neurological illnesses and conditions and for preventative treatment; pharmaceutical drugs in the nature of pharmaceutical preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and other preparations for destroying vermin; fungicides and herbicides; pharmaceutical preparations and substances for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for human use for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; pharmaceutical preparations for medical purposes and veterinary purposes, namely, for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; pharmaceutical preparations for medical use consisting of a cyclosporin as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions; pharmaceutical preparations for medical use consisting of a cyclosporin or another cyclophilin inhibitor as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions; pharmaceutical preparations for skin care; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the prevention of diseases of the nervous system; pharmaceutical preparations for the prevention of diseases of the metabolic system; pharmaceutical preparations for the prevention of disorders of the metabolic system; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for the prevention of tumors; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for the treatment of diseases caused by bacteria in the nature of antibacterial pharmaceuticals; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of disorders of the metabolic system; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of Parkinson's disease; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for the treatment of viral diseases in the nature of antivirals; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating heatstroke; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for use as immunosuppressive agents; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in organ transplantation; pharmaceutical preparations for use in tissue transplantation; pharmaceutical preparations for neurological conditions within the area of neurological intensive care; pharmaceutical preparations for the prevention of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; pharmaceutical preparations for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; medical and veterinary preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; phosphates for pharmaceutical purposes; phosphates for veterinary purposes; medical plasters; medical dressings; potassium salts for medical purposes; potassium salts for veterinary purposes; preparations for destroying vermin; quinine for medical purposes; quinine for veterinary purposes; mineral salts for medical purposes; sanitary preparations for medical purposes; sanitary preparations for veterinary purposes; slimming pills being medical preparations for slimming purposes; sodium salts for medical purposes; sodium salts for veterinary purposes; sulfonamide preparations; tinctures being medicinal drinks for medical purposes; tinctures being medicinal drinks for veterinary purposes; tonics being medicinal drinks; tonics being medicinal drinks for medical use; tonics being medicinal drinks for veterinary use; vaccines; vaccines for human use; veterinary vaccines; drugs and pharmaceutical preparations for acute and chronic neurological diseases and conditions including preventive treatment; diagnostic agents, preparations and substances for medical purposes Chromatography apparatus for laboratory use; DNA chips; electrodes for laboratory research Blood testing apparatus; electrodes for medical use; probes for medical purposes; probes for veterinary purposes; electrodes for veterinary use, namely, medical electrodes Analysis of human tissues for medical research; bacteriological analysis and consultation relating thereto; biochemical research; biological analysis; scientific biological laboratory services; biological research and analysis; biological research, medical research and clinical research in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; biological sample analysis for scientific and medical research purposes; biological samples, blood or other bodily fluids analysis services for scientific and medical research purposes; biotechnology research; blood analysis services; blood analysis services for scientific and medical research purposes; chemical analysis and research; chemical research and analysis services; chemistry consultancy services; clinical research in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; clinical research and trials for others in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; scientific research, namely, conducting clinical trials for others; conducting clinical trials being scientific research for others; conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of cosmetics, namely, consultancy in connection with the quality inspection, research and development of cosmetic products and medicated cosmetic products; consultancy in the field of sanitary research for medical purpose; consultancy in pharmaceutical, pharmacogenetics, medical chemistry, and veterinary research; consultancy services in the field of biological research; consultancy services in the field of biotechnology; consulting on pharmacogenetics in the nature of pharmaceutical consultation; cosmetics research; cosmetics research and analysis services; cosmetics research services and laboratory analysis services in the field of cosmetics; design and development of computer hardware and software; design and development of diagnostic apparatus and instruments for medical use; design and development of medical diagnostic apparatus and instruments; development, testing and consultancy services in the fields of biotechnology research, pharmaceutical research, medical research, veterinary medicine research, chemistry research, biology research, and pharmacogenetics research; DNA analysis for scientific and medical research purposes; drug and pharmaceutical discovery, testing and development services; drug discovery services; industrial analysis and research services in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; laboratory research services relating to pharmaceuticals; medical and veterinary product research and development and consultancy related thereto; medical laboratory services; medical research; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services; providing information in connection with all the aforementioned services; providing medical and veterinary testing services in the field of research relating to medicines, drug discovery, drug development and drug screening, and consultancy related thereto; research and development in the field of biotechnology; biochemical research and development of microorganisms and cells; research and development in the pharmaceutical and biotechnology fields; scientific research and development services; research and testing in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; research of pharmaceuticals; research relating to biotechnology; research relating to pharmaceuticals; research, development, and testing services, and consultancy related thereto, in the fields of biotechnology products, pharmaceutical products, sanitary products, medical products, veterinary products, chemistry products, biology products, and pharmacogenetics products; research, development, and testing services, and consultancy related thereto, in the fields of biotechnology, pharmaceuticals, sanitary products, chemistry, biology and pharmacogenetics; research, development, testing and consultancy services in the fields of biotechnology products, pharmaceutical products, medical products, sanitary products, veterinary products, chemistry products, biology products, and pharmacogenetics products; research, development, testing, scientific consultancy services in the fields of biotechnology products, pharmaceutical products, medical products, sanitary products, veterinary products, chemistry products, biology products, and pharmacogenetics products; research in the field of environmental protection; research, testing and development of sanitary, pharmaceutical, medical, medicinal chemical, veterinary preparations; research, testing and development of biotechnical, biological preparations; research, testing and development in the field of diagnostic preparations; research, testing and development of diagnostic preparations for medical purpose; scientific analysis in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases; scientific and technological services, namely, scientific research, analysis and testing in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, NASH, mitochondrial diseases and rare diseases, and research and design relating thereto; scientific laboratory services; scientific research; scientific research relating to cosmetics; testing of pharmaceuticals; blood toxicity analysis; toxicity testing in the nature of drug screening for research purposes; veterinary laboratory services Analysis of human serum for medical treatment; analysis of human tissues for medical treatment; consultancy in the field of cosmetics, namely, consultancy in connection with the selection of cosmetic products and medicated cosmetic products; consultancy in the medical field, namely, pharmacogenetics; consultancy in the medical field, other than dentistry; drug screening for medical purposes; health care; health care services; hygienic and beauty care for human beings or animals; medical and surgical diagnostic testing services; medical consultancy in the field of pharmacogenetics; medical consultancy services; medical diagnostic services in the nature of performing diagnosis of diseases; medical services; medical testing for diagnostic or treatment purposes; pharmaceutical consultancy services; providing information in connection with all the aforementioned services; rental of ultrasonic diagnostic apparatus; veterinary consultancy services; veterinary services

26.

Cell-permeable succinate compounds

      
Application Number 15128480
Grant Number 11147789
Status In Force
Filing Date 2015-04-08
First Publication Date 2017-04-20
Grant Date 2021-10-19
Owner ABLIVA AB (Sweden)
Inventor
  • Elmer, Eskil
  • Hansson, Magnus Joakim
  • Ehinger, Karl Henrik Johannes
  • Moss, Steven

Abstract

The present invention provides novel cell-permeable succinates and cell permeable precursors of succinateaimed at increasing ATP-production in mitochondria. The main part of ATP produced and utilized in the eukaryotic cell originates from mitochondrial oxidative phosphorylation, a process to which high-energy electrons are provided by the Kreb's cycle. Not all Kreb's cycle intermediates are readily permeable to the cellular membrane, one of them being succinate. The provision of the novel cell permeable succinates is envisaged to allow passage over the cellular membrane and thus the cell permeable succinates can be used to enhance mitochondrial ATP-output.

IPC Classes  ?

  • A61K 31/265 - Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
  • C07C 327/28 - Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
  • C07C 327/34 - Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups with amino groups bound to the same hydrocarbon radicals
  • C07C 327/32 - Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • C07C 327/30 - Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
  • A61K 31/155 - Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (HN=C(OH)NH2), isothiourea (HN=C(SH)—NH2)
  • A61K 31/22 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
  • C07D 211/76 - Oxygen atoms attached in position 2 or 6
  • A61P 11/00 - Drugs for disorders of the respiratory system
  • A61P 9/00 - Drugs for disorders of the cardiovascular system
  • A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system

27.

Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to Complex I-related impairment of mitochondrial oxidative phosphorylation

      
Application Number 15128496
Grant Number 10307389
Status In Force
Filing Date 2016-04-08
First Publication Date 2017-04-13
Grant Date 2019-06-04
Owner ABLIVA AB (Sweden)
Inventor
  • Elmer, Eskil
  • Hansson, Magnus Joakim
  • Ehinger, Karl Henrik Johannes
  • Piel, Sarah
  • Moss, Steven

Abstract

The present invention relates to a succinate prodrug for use in the treatment or prevention of lactic acidosis.

IPC Classes  ?

  • A61K 31/225 - Polycarboxylic acids
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61K 31/155 - Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (HN=C(OH)NH2), isothiourea (HN=C(SH)—NH2)

28.

NOVEL CELL-PERMEABLE SUCCINATE COMPOUNDS

      
Document Number 02944565
Status In Force
Filing Date 2015-04-08
Open to Public Date 2015-10-15
Grant Date 2022-11-29
Owner ABLIVA AB (Sweden)
Inventor
  • Elmer, Eskil
  • Hansson, Magnus Joakim
  • Ehinger, Karl Henrik Johannes
  • Moss, Steven

Abstract

The present invention provides novel cell-permeable succinates and cell permeable precursors of succinate aimed at increasing ATP-production in mitochondria of the following formula: The main part of ATP produced and utilized in the eukaryotic cell originates from mitochondrial oxidative phosphorylation, a process to which high-energy electrons are provided by the Kreb's cycle. Not all Kreb's cycle intermediates are readily permeable to the cellular membrane, one of them being succinate. The provision of the novel cell permeable succinates is envisaged to allow passage over the cellular membrane and thus the cell permeable succinates can be used to enhance mitochondria! ATP-output.

IPC Classes  ?

  • C07C 327/30 - Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
  • A61K 31/265 - Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
  • A61K 31/351 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
  • A61P 3/00 - Drugs for disorders of the metabolism
  • C07D 309/30 - Oxygen atoms, e.g. delta-lactones

29.

Protected succinates for enhancing mitochondrial ATP-production

      
Application Number 14433558
Grant Number 09670175
Status In Force
Filing Date 2013-10-04
First Publication Date 2015-09-17
Grant Date 2017-06-06
Owner ABLIVA AB (Sweden)
Inventor
  • Fliri, Hans Georg
  • Ford, Rhonan Lee
  • Scowen, David Arthur
  • Batcheller, Derek Gregory
  • Ehinger, Kari Henrik Johannes
  • Elmer, Mats Eskil
  • Hansson, Magnus Joakim
  • Sjovall, Karl Fredrik Lennart

Abstract

2 is independently a group according to formula (II) where formula (II) is as defined 10 herein.

IPC Classes  ?

  • A01N 43/26 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atom with two or more hetero atoms five-membered rings
  • A61K 31/335 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
  • C07C 69/34 - Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
  • C07C 69/52 - Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
  • C07D 317/34 - Oxygen atoms
  • C07C 69/40 - Succinic acid esters
  • C07C 69/708 - Ethers
  • C07D 323/00 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
  • C07C 235/06 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

30.

NEUROSTAT

      
Application Number 1223993
Status Registered
Filing Date 2014-06-10
Registration Date 2014-06-10
Owner Abliva AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for medical use consisting of a cyclosporin or another cyclophilin inhibitor as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions.

31.

Dosage form

      
Application Number 14348859
Grant Number 09504728
Status In Force
Filing Date 2012-10-24
First Publication Date 2014-08-21
Grant Date 2016-11-29
Owner ABLIVA AB (Sweden)
Inventor
  • Gregory, Matthew Alan
  • Moss, Steven James

Abstract

There is provided inter alia a pharmaceutical dosage form for oral administration comprising a sanglifehrin as active ingredient in which the sanglifehrin active ingredient is protected from acid degradation in the stomach environment following oral administration.

IPC Classes  ?

  • A61K 38/12 - Cyclic peptides
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 47/02 - Inorganic compounds
  • A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
  • A61K 9/08 - Solutions
  • A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
  • A61K 9/28 - DrageesCoated pills or tablets
  • A61K 31/5025 - PyridazinesHydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems

32.

Sanglifehrin derivatives and methods for their production

      
Application Number 13995666
Grant Number 09271977
Status In Force
Filing Date 2011-12-20
First Publication Date 2014-03-20
Grant Date 2016-03-01
Owner ABLIVA AB (Sweden)
Inventor
  • Moss, Steven James
  • Gregory, Matthew Alan
  • Wilkinson, Barrie
  • Kendrew, Steven Gary
  • Martin, Christine Janet

Abstract

There are provided inter alia compounds of formula (I) and (II) and their use in therapy, particularly for the treatment of viral infection.

IPC Classes  ?

  • A61K 31/5025 - PyridazinesHydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
  • C07D 491/107 - Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
  • A61P 31/18 - Antivirals for RNA viruses for HIV
  • A61P 31/14 - Antivirals for RNA viruses
  • A61K 31/501 - PyridazinesHydrogenated pyridazines not condensed and containing further heterocyclic rings
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

33.

Macrocyclic compounds and methods for their production

      
Application Number 14006341
Grant Number 09139613
Status In Force
Filing Date 2012-03-29
First Publication Date 2014-02-06
Grant Date 2015-09-22
Owner ABLIVA AB (Sweden)
Inventor
  • Moss, Steven James
  • Gregory, Matthew Alan
  • Wilkinson, Barrie

Abstract

There is provided inter alia compounds of formula (I): for use in treatment of viral infection or as an immunosuppressant.

IPC Classes  ?

  • A61K 38/06 - Tripeptides
  • C07K 5/083 - Tripeptides the side chain of the first amino acid being acyclic, e.g. Gly, Ala
  • C07K 5/065 - Dipeptides the side chain of the first amino acid containing carbocyclic rings, e.g. Phe, Tyr
  • C07K 5/06 - Dipeptides
  • C07D 498/04 - Ortho-condensed systems
  • C07D 498/06 - Peri-condensed systems

34.

Cyclosporine emulsion

      
Application Number 13877326
Grant Number 09040487
Status In Force
Filing Date 2011-09-30
First Publication Date 2013-12-05
Grant Date 2015-05-26
Owner ABLIVA AB (Sweden)
Inventor Elmér, Eskil

Abstract

The present invention relates to a cyclosporine emulsion containing: i) a cyclosporine ii) a natural oil (long chain triglyceride) iii) a phosphatidylcholine, iv) glycerol, v) a pharmaceutically tolerable alkali salt of a free fatty acid, vi) a medium chain triglyceride-oil vii) optionally, hydrochloric acid or sodium hydroxide for pH adjustment viii) water.

IPC Classes  ?

  • A61K 38/13 - Cyclosporins
  • A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
  • C07K 7/64 - Cyclic peptides containing only normal peptide links
  • A61K 9/107 - Emulsions
  • A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
  • A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
  • A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
  • A61K 47/24 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids

35.

Sanglifehrin based compounds

      
Application Number 13575212
Grant Number 09119853
Status In Force
Filing Date 2011-02-09
First Publication Date 2012-11-22
Grant Date 2015-09-01
Owner ABLIVA AB (Sweden)
Inventor
  • Moss, Steven James
  • Gregory, Matthew Alan
  • Wilkinson, Barrie
  • Martin, Christine Janet

Abstract

There are provided inter alia compounds of formula (I) useful as cyclophilin inhibitors.

IPC Classes  ?

  • C07D 498/08 - Bridged systems
  • C07D 413/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
  • A61K 31/50 - PyridazinesHydrogenated pyridazines

36.

Compound and methods for its production

      
Application Number 13433944
Grant Number 09090657
Status In Force
Filing Date 2012-03-29
First Publication Date 2012-10-04
Grant Date 2015-07-28
Owner ABLIVA AB (Sweden)
Inventor
  • Gregory, Matthew Alan
  • Moss, Steven James
  • Wilkinson, Barrie

Abstract

There is provided inter alia a compound of formula (I): for use in treatment of viral infection or as an immunosuppressant.

IPC Classes  ?

  • C07D 498/04 - Ortho-condensed systems
  • C07K 5/065 - Dipeptides the side chain of the first amino acid containing carbocyclic rings, e.g. Phe, Tyr
  • A61K 38/06 - Tripeptides
  • C07K 5/083 - Tripeptides the side chain of the first amino acid being acyclic, e.g. Gly, Ala
  • C07K 5/06 - Dipeptides
  • C07D 498/06 - Peri-condensed systems

37.

SANGLIFEHRIN DERIVATIVES AND METHODS FOR THEIR PRODUCTION

      
Document Number 02822347
Status In Force
Filing Date 2011-12-20
Open to Public Date 2012-06-28
Grant Date 2019-11-05
Owner ABLIVA AB (Sweden)
Inventor
  • Moss, Steven James
  • Gregory, Matthew Alan
  • Wilkinson, Barrie
  • Kendrew, Steven Gary
  • Martin, Christine Janet

Abstract

There are provided inter alia compounds of formula (I) and (II) and their use in therapy, particularly for the treatment of viral infection.

IPC Classes  ?

  • A61K 31/5025 - PyridazinesHydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
  • A61K 38/05 - Dipeptides
  • A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID]
  • A61P 31/12 - Antivirals
  • A61P 31/14 - Antivirals for RNA viruses
  • A61P 31/18 - Antivirals for RNA viruses for HIV
  • C07K 5/062 - Dipeptides the side chain of the first amino acid being acyclic, e.g. Gly, Ala
  • C12N 1/20 - BacteriaCulture media therefor
  • C12P 17/18 - Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
  • C12P 21/02 - Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

38.

SANGLIFEHRIN DERIVATIVES AND METHODS FOR THEIR PRODUCTION

      
Document Number 03028414
Status In Force
Filing Date 2011-12-20
Open to Public Date 2012-06-28
Grant Date 2021-01-26
Owner ABLIVA AB (Sweden)
Inventor
  • Gregory, Matthew Alan
  • Kendrew, Steven Gary
  • Martin, Christine Janet
  • Moss, Steven James
  • Wilkinson, Barrie

Abstract

There are provided inter alia compounds of formula (I) and (II) and their use in therapy, particularly for the treatment of viral infection.

IPC Classes  ?

  • C12P 21/02 - Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
  • A61K 31/504 - PyridazinesHydrogenated pyridazines forming part of bridged ring systems
  • A61P 31/14 - Antivirals for RNA viruses
  • C07K 5/062 - Dipeptides the side chain of the first amino acid being acyclic, e.g. Gly, Ala
  • C12N 1/20 - BacteriaCulture media therefor
  • C12P 17/18 - Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin

39.

CYCLOSPORINE EMULSION

      
Document Number 02812901
Status In Force
Filing Date 2011-09-30
Open to Public Date 2012-04-05
Grant Date 2019-02-19
Owner ABLIVA AB (Sweden)
Inventor Elmer, Eskil

Abstract

The present invention relates to a cyclosporine emulsion containing: i) a cyclosporine ii) a natural oil (long chain triglyceride) iii) a phosphatidylcholine, iv) glycerol, v) a pharmaceutically tolerable alkali salt of a free fatty acid, vi) a medium chain triglyceride-oil vii) optionally, hydrochloric acid or sodium hydroxide for pH adjustment viii) water.

IPC Classes  ?

40.

NEUROSTAT

      
Serial Number 85555773
Status Registered
Filing Date 2012-02-29
Registration Date 2013-06-04
Owner ABLIVA AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for medical use consisting of a cyclosporin as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions

41.

NEUROVIVE

      
Application Number 946112
Status Registered
Filing Date 2007-09-07
Registration Date 2007-09-07
Owner Abliva AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical and veterinary preparations; including medicines and pharmaceutical preparations for acute and chronic neurological illnesses and conditions (including preventive treatment); medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, brain damage, brain operations and other physical and neurological ailments of the brain; medicines and pharmaceutical preparations for use within the area of neurological intensive care; medicines and pharmaceutical preparations for use as immunosuppressive agents (e.g for organ transplant or other medical (and clinical) uses of immunosuppressive agents or preparations).

42.

NP

      
Application Number 940753
Status Registered
Filing Date 2007-08-31
Registration Date 2007-08-31
Owner Abliva AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth; dental wax; disinfectants; including medicines and pharmaceutical preparations for acute and chronic neurological illnesses and conditions (including preventive treatment); medicines and pharmaceutical preparations for neurosurgical conditions, brain damage, operations and similar; medicines and pharmaceutical preparations for use within the area of neurological intensive care; medicines and pharmaceutical preparations for use as immunosuppressive agents (e.g. organ transplant or other uses of immunosuppressive agents).